Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

كتاب المناعة في الطيور دكتور فارس الخياط

كتاب المناعة في الطيور دكتور فارس الخياط

  • Be the first to comment

كتاب المناعة في الطيور دكتور فارس الخياط

  1. 1. ‫ط‬ ‫ا‬ ‫رس‬ ‫ر‬ ‫دآ‬ ‫ــــ‬ ‫ا‬‫ر‬ ‫ا‬ : ‫ا‬ ‫أو‬ ‫ا‬ ‫آ‬Immunity or resistance‫أو‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ا‬‫ا‬ ‫ا‬"‫م‬ ‫أ‬ ‫أو‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬"‫ا‬ ‫ا‬ ‫ـ‬‫ـ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬Immunis‫ء‬ ‫ون‬ ‫ـ‬ ‫و‬ Exempt from duty‫أو‬ ‫ا‬ ‫ء‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫وآ‬ ‫وا‬ ‫اء‬ ‫ا‬ ‫آ‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬‫د‬ ‫أن‬ ‫و‬ ‫ا‬ ‫ا‬. ‫ه‬ ‫ي‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ك‬ ‫ا‬ ‫وا‬"‫ء‬ ‫ا‬ ‫ة‬"‫ض‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ن‬ ‫آ‬ ‫اء‬ ‫ا‬ ‫أوا‬ ‫أوا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫أو‬ ‫و‬ ‫ا‬‫ا‬ ‫ور‬ ‫و‬‫ا‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫وأدر‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ط‬ ‫و‬ ‫ا‬. ‫آ‬ ‫وا‬‫ا‬ ‫وه‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫م‬‫ا‬‫أو‬ ‫وي‬ ‫ا‬ ‫و‬ ‫ض‬The state of resistance to an infection‫ز‬ ‫ا‬ ‫ط‬ ‫ل‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫اء‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ا‬"‫آ‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫ء‬ ‫أ‬"‫ا‬ ‫أو‬) ‫ا‬ ‫ل‬=‫ا‬(‫ذ‬ ‫ن‬ ‫آ‬ ‫اء‬‫أو‬ ‫ا‬ ‫ا‬ ‫إ‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ل‬ ‫د‬ ‫ل‬ ‫أو‬ ‫ه‬ ‫أو‬ ‫أزا‬ ‫أو‬ ‫ء‬ ‫وا‬ ‫ا‬ ‫م‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ه‬ ‫ه‬ ‫و‬ ‫أو‬ ‫ه‬. ‫را‬ ‫ي‬ ‫ا‬ ‫وا‬‫ا‬ ‫و‬‫اض‬‫ف‬‫ا‬Immunology‫ع‬ ‫وه‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫را‬ ‫ي‬ ‫وا‬ ‫ا‬ ‫م‬ ‫ا‬ ‫وع‬: ١-‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫آ‬ ‫ا‬. ٢-‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ز‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫درا‬ ‫اض‬Resistance‫وا‬‫ا‬ ‫أو‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫أي‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬. ٣-‫ا‬ ‫ع‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫وآ‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫درا‬ ‫ا‬ ‫ت‬ ‫وا‬)‫ا‬ ‫ل‬=‫ا‬(‫ا‬ ‫ز‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫درا‬ ‫أي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫ا‬...‫دي‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫أن‬ ‫ل‬ ‫أن‬ ‫ر‬ ‫و‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫و‬ ‫وه‬ ‫أ‬ ‫و‬‫ا‬ ‫ح‬ ‫وا‬ ‫آ‬. ٤-‫ا‬ ‫وا‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫درا‬Immunosuppression‫و‬ ‫ا‬ ‫ت‬Failure of vaccination‫ا‬ ‫و‬ ‫ت‬ ‫ا‬ ‫ه‬ ‫ب‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اض‬ ‫وا‬ ‫وآ‬. ‫و‬‫دا‬ ‫أي‬ ‫ة‬ ‫ح‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫دات‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ر‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ل‬ ‫ع‬ ‫ا‬ ‫را‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ذا‬ ‫ا‬ ‫ه‬ ‫ا‬
  2. 2. ‫ذ‬ ‫ي‬ ‫أ‬ ‫د‬ ‫و‬ ‫ا‬ ‫ا‬‫ا‬ ‫ءة‬ ‫ا‬ ‫ن‬ ‫و‬ ً‫ا‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫دي‬ ‫ا‬ ‫دود‬ ‫ا‬ ‫و‬ ‫ن‬ ‫أ‬. ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ات‬ ‫أو‬-‫د‬ ‫ا‬ ‫ري‬ ‫ا‬ ‫ض‬ ‫و‬: ‫ن‬ ‫آ‬‫ض‬ ‫ا‬ ‫ا‬ ‫ه‬‫ا‬ ‫ا‬ ‫ب‬ ‫أ‬‫ة‬ ‫ا‬ ‫آ‬ ‫ر‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ن‬ ‫آ‬ ‫ن‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫ون‬ ‫ا‬ ‫أورو‬ ‫ن‬ ‫ض‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫م‬ ‫ك‬ ‫ه‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫و‬١٥٥٣‫م‬...‫دة‬ ‫ت‬ ‫و‬ ‫ك‬ ‫ه‬ ‫وآ‬‫ر‬ ‫ا‬ ‫ا‬: ١-‫ـ‬ ‫ا‬Variolation: ‫ه‬‫آ‬ ‫و‬ ‫ا‬ ‫أ‬ ‫ا‬‫و‬ ‫د‬ ‫ا‬ ‫ري‬ ‫ا‬ ‫و‬Variola‫أي‬‫ري‬‫و‬ ‫و‬ ‫ب‬ ‫ذة‬ ‫ري‬ ‫ات‬ ‫أ‬ ‫وي‬‫ي‬ ‫وآ‬ ‫ا‬ ‫ق‬ ‫ا‬: -‫ق‬ ‫ا‬Inhalation:‫وآ‬‫ا‬ ‫ا‬‫ا‬ ‫ا‬ ‫وح‬ ‫ا‬ ‫وا‬ ‫أن‬ ‫دوا‬ ‫أ‬‫ب‬ ‫ا‬ ‫و‬‫ا‬ ‫ا‬‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ض‬ ‫ا‬ ‫ا‬. -‫ا‬:‫ا‬ ‫ون‬ ‫ا‬ ‫آ‬ ‫وآ‬‫ا‬ ‫وح‬‫و‬ ‫د‬ ‫ا‬ ‫ري‬ ‫ا‬ ‫ص‬ ‫ا‬‫و‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ض‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ون‬ ‫ا‬ ‫آ‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫زو‬ ‫و‬ ‫ا‬ ‫ا‬. ٢-‫ـ‬ ‫ا‬Vaccination: ‫و‬ ‫ض‬ ‫ا‬ ‫و‬ ‫ن‬ ‫ا‬ ‫ب‬ ‫إآ‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ف‬"ً"‫أو‬"ً"‫أو‬Vaccination ‫آ‬ ‫ا‬Vacca‫أي‬‫ة‬‫ح‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫أ‬ ‫آ‬Vaccine. ‫و‬‫أآ‬ ‫ا‬‫ي‬ ‫ا‬‫إدوارد‬١٧٤٩-١٨٢٣‫م‬‫ي‬ ‫ا‬‫أن‬‫ر‬ ‫ا‬"‫ن‬ ‫آ‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ري‬"‫وأ‬‫ا‬‫ا‬ ‫ري‬cowpox‫ا‬‫ي‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ري‬ ‫ص‬ ‫ا‬ ‫و‬ ‫را‬ ‫ا‬ ‫وح‬ ‫وأ‬ ‫ذ‬ ‫م‬ ‫أن‬ ‫ر‬ ‫ن‬ ‫ا‬ ‫و‬ ‫ص‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ورا‬ ‫ء‬ ‫ا‬‫د‬ ‫ا‬ ‫ري‬ ‫ا‬ ‫أ‬‫ا‬ ‫ت‬ ‫ا‬ ‫و‬‫ا‬ ‫آ‬ ‫ا‬ ‫أ‬ ‫ا‬. -‫ا‬‫ف‬‫ا‬‫ت‬ ‫و‬ttenuationLaboratory a: ‫ت‬ ‫و‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫ف‬ ‫أآ‬ ‫ا‬Attenuation‫ا‬١٨٢٢- ١٨٩٥‫م‬‫و‬‫ح‬ ‫ج‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ح‬ ‫آ‬ ‫أ‬‫ج‬ ‫ا‬ ‫ا‬ ‫آ‬Fowl cholera‫م‬١٨٨٠‫م‬‫ا‬ ‫داء‬ ‫ح‬ ‫ج‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ل‬ ‫أ‬ ‫ن‬ ‫وآ‬Rabies‫و‬‫ح‬ ‫ج‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ض‬Anthrax‫م‬١٨٨١‫ع‬ ‫أ‬ ‫و‬ ‫م‬‫ـ‬ ‫ا‬ ‫آ‬ ‫ل‬ ‫أن‬ Vaccination‫ح‬ ‫آ‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ام‬ ‫أ‬ ‫أ‬. -‫ا‬ ‫ف‬ ‫أآ‬Phagocytosis: ‫ف‬ ‫أآ‬ ‫ا‬‫ا‬ ‫ة‬ ‫ه‬Phagocytosis‫ف‬ ‫أ‬ ‫ا‬ ‫و‬ ‫ا‬‫م‬١٨٨٢‫م‬ ‫أ‬ ‫أ‬ ‫ء‬ ‫أ‬‫ا‬ ‫ه‬ ‫وأن‬ ‫ك‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ت‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫ع‬ ‫ك‬ ‫ه‬ ‫أن‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ف‬ ‫ح‬ ‫ء‬ ‫أ‬ ‫آ‬ ‫و‬ ‫ك‬ Phagocytes‫آ‬ ‫أن‬Phages‫وآ‬ ‫آ‬Cite‫ا‬ ‫ه‬ ‫و‬‫ا‬ Phagocytosis‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ه‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫ذ‬ ‫وا‬ ‫و‬.
  3. 3. ‫را‬-‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ف‬ ‫أآ‬Antibodies: ‫ا‬ ‫ا‬ ‫آ‬ ‫رل‬ ‫آ‬ ‫وي‬ ‫ا‬ ‫ا‬ ‫درس‬ ‫ا‬ ‫ن‬ ‫ا‬ ‫أوا‬‫دة‬ ‫ا‬ ‫م‬ ‫أ‬ ‫ا‬ ‫واآ‬ ‫س‬ ‫رن‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫ا‬ ‫ت‬ ‫ل‬ ‫و‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫إ‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫أن‬ ‫إ‬ ‫و‬ ‫م‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ت‬ ‫آ‬ ‫ت‬. ‫و‬‫وا‬ ‫ا‬ ‫ل‬ ‫ر‬ -‫م‬١٥٦٥‫س‬ ‫و‬ ‫ه‬ ‫ا‬ ‫م‬ ‫م‬١٥٣٧-١٦١٩‫ا‬ ‫ا‬ ‫ف‬ ‫آ‬ ‫م‬Cloacal bursa‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫و‬ ‫ة‬ ‫ة‬ ‫ل‬ ‫و‬ ‫ا‬ ‫ا‬Bursa of Fabricius‫و‬ ‫أ‬‫م‬ ‫آ‬١٩٥٦‫ر‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫أ‬ ‫م‬ ‫م‬ ‫ا‬ ‫آ‬ ‫وا‬ ‫و‬ ‫ف‬ ‫وس‬ ‫ا‬ ‫ا‬ ‫وه‬ ‫وا‬ ‫ا‬ . -‫م‬١٨٨٠‫وب‬ ‫أ‬ ‫ف‬ ‫ا‬ ‫ع‬ ‫أ‬ ‫م‬‫ا‬ ‫أ‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬Fowl cholera‫أ‬ ‫و‬ ‫ض‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ح‬ ‫ا‬‫ة‬‫ا‬ ‫ر‬ ‫ا‬ . -‫م‬١٩٤٠‫ء‬ ‫آ‬ ‫ا‬ ‫أ‬ ‫وأ‬ ‫آ‬ ‫ا‬ ‫ة‬ ‫أول‬ ‫أ‬ ‫م‬ ‫وى‬ ‫ا‬. -‫م‬١٩٦٥‫و‬ ‫أول‬ ‫آ‬ ‫م‬‫وس‬ ‫ي‬ ‫اد‬ ‫ا‬ ‫ر‬ ‫اد‬ ‫ا‬ ‫أه‬ ‫و‬ ‫رو‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ذ‬ ‫ب‬ ‫إ‬ ‫ح‬ ‫آ‬ ‫و‬ ‫ض‬ ‫ن‬ ‫رو‬ ‫ا‬ ‫إ‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ول‬ ‫ا‬ ‫رو‬ ‫ا‬ ‫وس‬‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫رو‬ ‫ا‬. -‫م‬١٩٧٠‫ح‬ ‫ا‬ ‫ه‬ ‫ض‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫م‬ ‫ا‬ ‫ح‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ر‬ ‫ض‬ ‫ح‬ ‫و‬ ‫ا‬ ‫ة‬ ‫م‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫أ‬ ‫م‬ ‫ي‬ ‫ا‬ ‫ق‬ ‫ا‬ ‫ول‬ ‫ا‬. -‫م‬١٩٧٥‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫أول‬ ‫أت‬ ‫م‬‫م‬ ‫ي‬ ‫ا‬ ‫واردن‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ض‬ ‫ب‬ ‫ه‬ ‫ا‬ ‫ح‬ ‫ذ‬ ‫وا‬ ‫م‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ح‬ ‫ا‬-١‫ا‬ ‫ح‬ ‫ا‬ ‫ن‬ ‫إ‬ ‫دي‬ ‫ا‬ ‫ح‬ ‫ا‬ ‫أن‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫واردن‬ ‫م‬ ‫و‬ ‫ر‬ ‫اآ‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫د‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ت‬ ‫ل‬ ‫وأ‬ ‫ا‬ ‫أ‬. -‫ل‬١٩٨٢–١٩٨٣‫ة‬ ‫ام‬ ‫أ‬ ‫وا‬ ‫ا‬ ‫ل‬ ‫ن‬ ‫أ‬ ‫ء‬ ‫ا‬ ‫ض‬‫ج‬ ‫ا‬ ‫ح‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫وه‬ ‫ر‬١٨‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫م‬ ‫ت‬ ‫ت‬ ‫ا‬ ‫ا‬"‫ا‬Innovation = In ovo vaccination"‫ه‬ ‫أ‬ ‫و‬ ‫ا‬‫ا‬ ‫أ‬ ‫ء‬ ‫ا‬‫ة‬ ‫ا‬ ‫و‬ ‫ا‬‫ي‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا‬ ‫ض‬ ‫أ‬. -‫م‬٢٠١٠‫اآ‬ ‫ام‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ة‬ ‫و‬ ‫م‬Recombinant vaccine‫دات‬ ‫ا‬ ‫ة‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫وس‬ ‫را‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ذة‬ ‫ا‬ ‫ا‬H5N1‫ي‬ ‫ا‬ ‫زر‬ ‫أو‬ ‫ص‬ ‫ا‬ ‫م‬ ‫ا‬ ‫أو‬ ‫را‬ ‫ا‬‫ا‬ ‫وذ‬ ‫ر‬ ‫ا‬ ‫ري‬ ‫وس‬.
  4. 4. ‫ت‬ ‫وا‬ ‫ا‬ ‫ل‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫أ‬ ‫ول‬: ‫ا‬ ‫ا‬‫ر‬ ‫ا‬‫ت‬ ‫ا‬ ‫س‬ ‫و‬ ‫ه‬١٥٣٧- ١٦١٩‫م‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫اب‬ ‫ف‬ ‫أآ‬١٥٦٥‫م‬. ‫ك‬ ‫ن‬ ‫أ‬ ١٦٣٢- ١٧٢٣‫م‬ ‫ا‬ ‫اع‬ ‫أ‬‫ا‬ ‫ب‬ ‫و‬١٦٧٤‫م‬. ‫ا‬---- ‫د‬ ‫ا‬ ‫ري‬ ‫ا‬ ‫ات‬ ‫م‬ ‫أ‬Variolation‫ا‬ ‫ل‬١٧١٣‫م‬. ‫وار‬ ‫ري‬----‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬١٧١٨‫م‬. ‫إدوارد‬ ١٧٤٩- ١٨٢٣‫م‬ ‫ا‬ ‫ري‬ ‫ات‬ ‫م‬ ‫ا‬Vaccination‫ري‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬١٧٩٨‫م‬. ١٨٢٢- ١٨٩٥‫م‬ ‫ت‬ ‫و‬ ‫ا‬ ‫أ‬Attenuation‫و‬ ‫وأ‬ ‫ر‬ ‫وا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫وب‬ ‫و‬ ‫ا‬. ‫خ‬ ‫آ‬ ‫ت‬ ‫رو‬* ١٨٤٣‫ـ‬ ١٩١٠‫م‬ ‫ا‬ ‫ه‬ ‫و‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أآ‬‫د‬. ‫ف‬ ‫أ‬* ١٨٤٥- ١٩١٦‫م‬ ‫ا‬ ‫ة‬ ‫ه‬ ‫أآ‬Phagocytosis١٨٨٢‫م‬ ‫إ‬ ‫ول‬ ١٨٥٤- ١٩١٥‫م‬ ‫ا‬ ‫رة‬ ‫ت‬ ‫ا‬ ‫أن‬ ‫ا‬ ‫ن‬ ‫ا‬ ‫أوا‬ ‫أآ‬ ‫ا‬ ‫ا‬. ‫روو‬ ‫ر‬ ‫أ‬١٨٦٣- ١٩٤٣‫م‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أن‬ ‫أآ‬‫م‬ ‫ر‬Exotoxins١٨٨٨‫م‬. ١٨٥٤- ١٩١٧‫م‬ ‫ن‬ ‫إ‬ ‫رو‬ ‫آ‬١٨٥٣- ١٩٣١‫م‬ ‫ا‬ ‫م‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫أآ‬Antitoxin١٨٩٠‫م‬ ‫أدوارد‬ ١٨٦٠- ١٩١٧‫م‬ ‫ا‬ ‫أآ‬complement١٨٩٣‫م‬. ‫رل‬ ‫آ‬ ١٨٦٨- ١٩٤٣‫م‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫أآ‬Antibodies‫ا‬ ‫ن‬ ‫ا‬ ‫أوا‬. +‫ن‬ ‫را‬ ‫ا‬ ‫ام‬ ‫أ‬ ‫وأ‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أن‬ ‫أآ‬ ‫آ‬ ‫وأ‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ح‬ ‫آ‬ ‫ر‬ ‫ا‬Toxoid ١٩٢٣. ١٩٠٢- ١٩٧١‫م‬ ‫س‬ ‫أر‬ ‫آ‬ ‫أ‬‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫أآ‬ ‫ت‬Gamma globulins‫ا‬ ‫ن‬ ‫ا‬ ‫ت‬. ١٩٤٠‫م‬‫آ‬ ‫ا‬ ‫ض‬ ‫ة‬ ‫أول‬ ‫ام‬ ‫أ‬١٩٤٠‫م‬. ‫وس‬ ‫ا‬‫ا‬ ‫ا‬ ‫أآ‬‫ر‬ ‫ا‬١٩٥٦‫م‬. ‫ر‬ ‫اد‬ ‫ا‬‫ــ‬ ‫رو‬ ‫ا‬ ‫ض‬ ‫أول‬ ‫ام‬ ‫أ‬١٩٦٥‫م‬. ‫ر‬ ‫ض‬ ‫ح‬ ‫و‬ ‫ا‬ ‫ة‬١٩٧٠‫م‬. ‫واردن‬ ‫ا‬‫ح‬ ‫ا‬ ‫ا‬ ‫ا‬+‫آ‬ ‫ا‬ ‫ح‬١٩٧٥‫م‬. ١٩٢٧- ٢٠٠٢‫م‬ ‫ار‬* ‫ه‬ ‫آ‬ ‫رج‬*١٩٤٦- ١٩٩٥‫م‬ ‫ا‬ ‫ة‬ ‫و‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫أ‬Monoclonal antibodies ١٩٧٥‫م‬. ‫ء‬ ‫أ‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ام‬ ‫أ‬In ovo vaccination = Innovation‫ر‬ ‫ض‬١٩٨٢–١٩٨٣‫م‬. *‫ة‬ ‫ا‬ ‫ء‬.
  5. 5. ‫آ‬‫وو‬‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ of the avian Immune Systemand functionsStructure ‫إن‬‫ا‬‫و‬ ‫اض‬ ‫ا‬ ‫و‬ ‫رة‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ء‬ ‫ور‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ز‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ض‬Acquired immune deficiency Syndrome = AIDS‫ن‬ ‫ا‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫اض‬ ‫أ‬ ‫وآ‬‫رو‬ ‫ا‬‫ا‬ ‫ج‬ ‫ا‬ ‫وأ‬ ‫ز‬ ‫وا‬ ‫ر‬ ‫ض‬ ‫و‬ ‫رة‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ذ‬ ‫ا‬ ‫أو‬ ‫ه‬ ‫ا‬ ‫م‬ ‫وا‬ ‫ا‬ ‫وس‬ ‫وا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ا‬‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أ‬ ‫ذا‬. ‫ا‬ ‫ز‬ ‫ا‬ ‫و‬:‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫و‬: ١-‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬"Self"‫ا‬ ‫ا‬ ‫وا‬"Non self"‫م‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ت‬ ‫أ‬ ‫اث‬ ‫ا‬ ‫ز‬ ‫ا‬‫اض‬ ‫أ‬ ‫ا‬ ‫دي‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫وه‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫اض‬ ‫ا‬ ‫ه‬ ‫و‬ ‫و‬ ‫ذا‬"‫ا‬ ‫ا‬ ‫ا‬ ‫اض‬ ‫أ‬Autoimmune diseases"‫و‬ ‫ا‬ ‫اع‬ ‫أ‬ ً ‫و‬)‫ا‬(‫ه‬ ‫و‬ ‫ب‬ ‫ا‬ ‫ا‬ ‫ض‬ ‫و‬...‫و‬ ‫أن‬ ‫آ‬‫ر‬ ‫ا‬ ‫وث‬ ‫ا‬ ‫درة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ه‬. ٢-‫آ‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫و‬ ‫أي‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ا‬.‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ت‬. ٣-‫آ‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫و‬ ‫أي‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ا‬‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ح‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ت‬. ٤-‫ا‬ ‫ة‬ ‫اآ‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ء‬ ‫و‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫اذا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ة‬ ‫ذاآ‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ا‬‫أو‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫اذا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ه‬ ‫ز‬ ‫ة‬ ‫و‬ ‫ي‬ ‫أ‬ ‫ات‬. ‫ر‬ ‫ـ‬‫ــ‬ ‫ا‬ ‫ـ‬‫ـ‬ ‫ا‬ ‫ز‬ ‫ـ‬ ‫ـ‬‫ـ‬ ‫وا‬ ‫ا‬ ‫دئ‬ ‫ا‬ ‫ت‬ ‫و‬ ‫أي‬ ‫أن‬ ‫آ‬ ‫و‬ ‫ر‬ ‫ووا‬ ‫ة‬ ‫آ‬ ‫اذا‬ ‫ه‬ ‫ـ‬ ‫و‬ ‫ن‬‫آ‬ ‫ا‬ ‫ـ‬ ‫ا‬ ‫ت‬ ‫ـ‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ا‬. ‫أ‬ ‫أو‬ ‫م‬ ‫أ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫را‬ ‫أ‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ر‬ ‫أ‬ ‫و‬. ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ن‬ ‫آ‬ ‫وا‬ ‫وا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫و‬‫آ‬ ‫آ‬ ‫ر‬ ‫آ‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ء‬ ‫ا‬: ‫أو‬-‫ا‬ ‫ء‬ ‫ا‬:‫و‬ ‫دي‬ ‫ة‬ ‫ا‬ ‫و‬ ‫ن‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫ث‬ ‫و‬ ‫و‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬ ‫دة‬‫ا‬ ‫ة‬. -‫ا‬ ‫ا‬:‫وا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ذات‬ ‫ا‬ ‫ة‬ ‫اع‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫در‬ ‫أ‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫أ‬ ‫وا‬ ‫ا‬. -‫ا‬ ‫ا‬:‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ة‬ ‫وه‬‫ا‬ ‫ز‬-‫وا‬-‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫وا‬Dendertic cells‫آ‬ ‫آ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫وا‬Chemical messengers ‫ت‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫رات‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬...‫وف‬ ‫ا‬ ‫د‬ ‫وا‬ ‫ن‬ ‫ا‬٩٠‫ع‬..‫أ‬ ‫د‬ ‫وا‬ ‫ا‬ ‫و‬. ‫أو‬-‫ا‬ ‫ء‬ ‫ا‬:‫وه‬ ‫دة‬ ‫و‬ ‫ت‬ ‫أو‬ ‫اع‬ ‫أ‬: ‫أ‬-‫ا‬ ‫ء‬ ‫ا‬mitive or originative organsPri:‫أ‬‫و‬ ‫ا‬ ‫ا‬‫ا‬ ‫وا‬ ‫ة‬ ‫ا‬ ‫ا‬Undifferentiated–Unprogrammed stem cells‫و‬‫ا‬ ‫ه‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫آ‬ ‫ا‬ ‫ر‬ ‫ا‬‫و‬‫ا‬ ‫ء‬ ‫ا‬‫آ‬:
  6. 6. -‫ا‬ ‫آ‬cYolk sa:‫ن‬‫ا‬ ‫آ‬‫ا‬ ‫ا‬ ‫ه‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫را‬ ‫ا‬ ‫و‬ ‫م‬ ‫أ‬ ‫ا‬ ‫و‬ ‫ب‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ر‬ ‫و‬ ‫و‬ ‫ا‬ ‫أو‬ ‫ول‬ ‫ا‬ ‫م‬ ‫ا‬ ‫را‬ ‫أ‬ ‫ا‬ ‫ة‬ ‫ا‬‫ا‬ ‫ر‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ع‬ ‫ا‬. -‫ا‬ ‫ا‬Fetal liver:‫ـ‬ ‫ا‬ ‫م‬ ‫ا‬ ‫آ‬ ‫و‬١٢‫ا‬ ‫و‬ ‫ا‬. -‫م‬ ‫ا‬ ‫ع‬Bone marrow:‫ـ‬ ‫ا‬ ‫م‬ ‫ا‬ ‫آ‬ ‫و‬١٢‫ا‬ ‫ة‬ ‫ي‬ ‫وا‬. ‫ب‬-‫و‬ ‫ا‬ ‫أو‬ ‫ي‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬‫ا‬ ‫أو‬Maturation organs=Central=Primary: ‫أس‬ ‫ا‬ ‫ه‬ ‫أ‬Cranial organ‫ا‬ ‫أو‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫وه‬Thymus ‫ا‬ ‫وا‬Caudal organ‫أو‬ ‫آ‬ ‫وه‬‫ا‬Bursa of Fabricius‫ا‬ ‫ا‬ ‫أو‬ Cloacal bursa. ‫ن‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫وه‬‫و‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫أ‬"Lymphocytes..." ‫ا‬ ‫ل‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫إ‬ ‫ي‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫وا‬ ‫آ‬ ‫ا‬ ‫ن‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫إ‬‫ا‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ل‬. -‫ا‬ ‫ة‬ ‫ا‬Thymus gland: ‫ص‬ ‫ا‬ ‫أزواج‬ ‫ن‬ ‫ة‬ ‫ه‬‫ن‬ ‫ا‬‫ا‬ ‫ا‬ ‫ا‬‫ر‬ ‫ا‬‫ة‬ ‫ا‬ ‫و‬ ‫أآ‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬"٦-١٦"٣-٤‫أن‬ ‫إ‬ ‫ر‬ ‫ا‬ ‫غ‬ ‫ا‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫د‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫م‬ ‫ؤل‬ ‫ا‬. ‫س‬ ‫ا‬ ‫ة‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫وا‬‫ا‬ ‫أ‬"Pre-thymic cells"‫ا‬‫ت‬ ‫ه‬ ‫أ‬ ‫س‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ة‬ ‫ا‬"‫وا‬"‫و‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬-Thymic-derived or T- Lymphocytes‫و‬‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬Cell-mediated Immunity. ‫اب‬ ‫أو‬ ‫آ‬Bursa of Fibricius: ‫ر‬ ‫ا‬ ‫ا‬ ‫وي‬ ‫ه‬‫وأآ‬‫م‬١٥٦٥‫س‬ ‫و‬ ‫ه‬ ‫ا‬ ‫م‬ "١٥٣٧-١٦١٩‫م‬"‫م‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫أ‬ ‫و‬١٩٥٦‫ا‬ ‫م‬ ‫ا‬‫وس‬‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ت‬ ‫أ‬. ‫و‬‫ه‬‫ا‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫وي‬ ‫آ‬ ‫آ‬Cloacal bursa‫ت‬ ‫ا‬ ‫و‬ Plicae‫ده‬ ‫اوح‬ ‫وا‬٢٢"١٥‫و‬ ‫أو‬٧"‫ت‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ت‬ ‫ا‬‫ز‬ ‫و‬ ‫و‬ ‫و‬ ‫ا‬...‫ا‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫و‬ ‫ا‬ ‫دس‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫م‬ ‫د‬ ‫زد‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ؤل‬ ‫ا‬ ‫ذ‬ ‫ا‬ ‫ا‬‫ل‬ ‫ا‬ ‫د‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫م‬ ‫ا‬ ‫غ‬ ‫ا‬ ‫ا‬. ‫ا‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫وا‬‫ا‬ ‫أ‬"Pre-bursal cells" ‫ا‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬‫ا‬‫أ‬‫ا‬ ‫ت‬ ‫ه‬ "‫ر‬ ‫ا‬urosopoetin"‫و‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬-Bursal-derived or B- Lymphocytes‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫وه‬Antibody-mediated Immunity. ‫ج‬-‫ي‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬seeding organs=peripheral=Secondary: ‫ا‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ي‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫أن‬ ‫ذآ‬‫ت‬‫ا‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ل‬ ‫آ‬ ‫ا‬ ‫ن‬ ‫ا‬ ‫ه‬‫ة‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫و‬ ‫ن‬ ‫ا‬‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫إ‬ ‫ي‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ـ‬Immune migration‫أو‬Peripheralization process‫ا‬ ‫ز‬ ‫ا‬ ‫أ‬ ‫و‬
  7. 7. ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫را‬ ‫أ‬ ً ‫ر‬ ‫ا‬ ‫ا‬٦-٨‫ة‬ ‫ء‬ ‫أ‬ ‫و‬ ‫أ‬ ‫آ‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫دور‬ ‫ي‬ ‫ا‬ ‫ي‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫و‬ ‫غ‬ ‫ا‬ ‫ا‬ ‫ل‬ ‫و‬ ‫د‬ ‫و‬ ‫ن‬ ‫و‬ ‫ر‬ ‫ا‬ ‫س‬ ‫ا‬ ‫ة‬ ‫و‬ ‫ا‬ ‫ا‬‫و‬‫ء‬ ‫ا‬ ‫ه‬: ١-‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬:‫ت‬ ‫وه‬ ‫ا‬ ‫ز‬ ‫آ‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ة‬ ‫و‬ ‫دة‬ ‫و‬ ‫وا‬ ‫وا‬ ‫وا‬‫ـ‬ ‫ف‬ ‫و‬Mucosal associated lymphoid tissues "MALT"..‫و‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ه‬: -‫ـ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬Skin associated lymphoid tissue = SALT. -‫ا‬ ‫ز‬ ‫ـ‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬Gut associated LT = GALT. -‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬Bronchial associated LT = BALT. -‫أس‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬Head associated LT = HALT. ‫ت‬ ‫ا‬ ‫وه‬‫ا‬‫ا‬ ‫ا‬ ‫م‬ ‫ا‬‫ا‬ ‫ه‬‫ة‬ ‫ه‬‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ Mucosal or Local Immunity‫اض‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫ا‬. ٢-‫و‬ ‫ء‬ ‫أ‬Uncapsulated lymphoid organs‫ا‬ ‫و‬: -‫ردر‬ ‫ه‬ ‫ة‬Harderian gland:‫ا‬ ‫ا‬‫او‬‫ا‬‫ا‬‫ر‬ ‫ا‬Medial canthus of the eye ‫و‬‫أآ‬‫ول‬‫م‬ ‫ة‬١٦٩٤‫ا‬ ‫م‬‫ردر‬ ‫ه‬ ‫ب‬ ‫آ‬ ‫ن‬ ‫ه‬"١٦٥٦-١٧١١‫م‬"‫و‬ ‫ا‬ ‫ت‬ ‫أ‬ ‫و‬ ‫آ‬ ‫ا‬٥‫اء‬ ‫وإ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ت‬ ‫رة‬ ‫م‬١٠‫ة‬ ‫ا‬ ‫ن‬ ‫م‬‫ظ‬ ‫ا‬ ‫و‬ ‫د‬‫ا‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬- ٢٠%‫وا‬-٨٠%‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫وا‬‫ا‬ ‫و‬‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬‫ي‬ ‫آ‬‫د‬ ‫و‬ ‫دا‬ ‫وأ‬‫ه‬‫ت‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ر‬ ‫ي‬ ‫وا‬ ‫ا‬ ‫ا‬‫ا‬‫ا‬ ‫أو‬ ‫ا‬. -‫ج‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬Esophageal tonsils:‫ة‬ ‫ا‬ ‫ج‬ ‫ا‬ ‫ن‬ ‫و‬ ‫ا‬٦-٨‫و‬‫ا‬ ‫و‬ ‫ات‬‫ا‬-‫و‬ ‫ا‬ ‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ا‬-‫ـ‬ ‫ا‬ ‫آ‬MHC-2‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ا‬ ‫ا‬ ‫رو‬ ‫ا‬ ‫وس‬ ‫ث‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬. -‫ز‬ ‫ا‬‫ر‬ ‫ا‬Cecal tonsils:‫ا‬ ‫ء‬ ‫ر‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫ا‬ ‫ت‬ ‫أ‬Ilieocecal junction‫ن‬ ‫و‬‫ر‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫وي‬‫ا‬ ‫و‬‫آ‬
  8. 8. ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫ا‬"‫ا‬-٥٠%‫وا‬-٥٠%‫ا‬ ‫ا‬ ‫و‬ ‫ا‬". -‫و‬ ‫ا‬ ‫ت‬ ‫ا‬Lymphoid follicles:‫ا‬ ‫ا‬ ‫و‬ ‫آ‬ ‫ه‬ ‫أه‬ ‫و‬ ‫ء‬ ‫وا‬ ‫ا‬ ‫وا‬‫أ‬‫ـ‬ ‫ا‬ ‫أو‬Payer's Patches‫و‬‫ء‬ ‫ا‬ ‫ا‬. -‫ا‬ ‫ا‬ ‫أو‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬Lymphoid or annular rings:‫آ‬ ‫دا‬ ‫أ‬ ‫أر‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫و‬ ‫وا‬. -iclums divert'Mickel:‫ه‬‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬‫ن‬ ‫ا‬ ‫وه‬ ‫و‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫وي‬ ‫ا‬ ‫اآ‬ ‫ا‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ء‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ي‬ ‫ا‬٢-٥ ‫و‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ن‬ ‫ا‬ ‫أ‬٥-٧‫اآ‬ ‫ن‬ ‫ا‬ ‫أ‬ ‫وي‬ ‫ا‬ ‫ا‬ ‫و‬ ‫از‬ ‫أ‬ ‫د‬١٠‫و‬ ‫أه‬ ‫و‬ ‫و‬ ‫أ‬ ‫ا‬ ‫اء‬ ‫أ‬-‫رد‬ ‫ه‬ ‫ة‬ ‫ا‬ ‫رب‬ ‫ز‬ ‫ا‬ ‫و‬. -‫ا‬ ‫ة‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬‫س‬ ‫ا‬ ‫ة‬ ‫و‬:‫ة‬ ‫ا‬ ‫أ‬ ‫و‬ ‫آ‬ ‫ه‬ ‫ا‬Proventriculus‫س‬ ‫ا‬ ‫ة‬ ‫و‬Pancreas. -‫م‬ ‫ا‬ ‫ع‬Bone marrow:‫ا‬ ‫ء‬ ‫ا‬ ‫أ‬ ‫آ‬ ‫ا‬ ‫ي‬ ‫آ‬ ‫ا‬. ٣-‫ا‬ ‫و‬ ‫ا‬ ‫ء‬ ‫ا‬psulated lymphoid organsCa‫ا‬ ‫و‬:: -‫ل‬ ‫ا‬Spleen:‫ا‬ ‫ة‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫أه‬ ‫ه‬Graveyard or burial ground ‫ج‬ ‫ا‬ ‫ا‬ ‫وي‬ ‫وه‬"‫ج‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أ‬"‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫و‬ ‫دة‬ ‫و‬ ‫وا‬‫ل‬ ‫ا‬ ‫ن‬ ‫و‬ ‫ج‬ ‫ا‬ ‫و‬ ‫أ‬ ‫ل‬ ‫أآ‬ ‫ا‬ ‫و‬ ‫وا‬ ‫ل‬: -‫ا‬ ‫ب‬ ‫ا‬Red pulp:‫و‬٤٠%‫ا‬ ‫اء‬ ‫د‬ ‫ن‬ ‫و‬ ‫و‬ ‫ا‬ ‫ا‬ ‫أي‬ ‫ا‬ ‫و‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫و‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬. -‫ا‬ ‫ب‬ ‫ا‬White pulp:‫ا‬٥٠%‫و‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫اد‬ ‫أ‬ ‫ا‬ ‫و‬‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫آ‬)(٧٠%‫ا‬)(٣٠%‫ا‬ ‫ا‬ ‫و‬ ‫ا‬. ‫ل‬ ‫ا‬ ‫و‬: -‫ا‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ل‬ ‫ا‬‫ا‬ ‫أو‬ ‫ا‬ ‫اء‬ ‫ا‬ ‫م‬ ‫ا‬. -‫ا‬‫ل‬‫وا‬ ‫ا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ة‬ ‫آ‬ ‫اد‬ ‫أ‬-‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬‫ض‬ ‫و‬ ‫ت‬ ‫ا‬Antigen presenting and processing. -‫ا‬ ‫ة‬ ‫آ‬ ‫اد‬ ‫أ‬ ‫ا‬-‫وا‬-‫دة‬ ‫ا‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ج‬ ‫م‬ ‫ا‬ ‫ء‬ ‫ا‬. -‫ا‬‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ج‬ ‫ل‬ ‫ا‬ ‫م‬Granulopioeosis‫و‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫ا‬Lymphopioeosis." -‫رال‬Mural Body:‫ه‬‫ر‬‫آ‬ ‫ا‬ ‫وي‬ ‫ا‬ ‫ء‬ ‫ا‬Large lymphatic duct‫ذ‬ ‫و‬ ‫ر‬ ‫ا‬ ‫و‬ ‫أن‬ ‫و‬ ‫ا‬ ‫ذ‬ ‫ا‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ي‬ ‫ا‬. -‫ي‬ ‫ا‬ ‫ا‬Pineal body:‫أس‬ ‫ا‬ ‫ة‬‫ء‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ي‬ ‫ا‬‫م‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫آ‬ ‫س‬ ‫وه‬ ‫ا‬ ‫ق‬ ‫ا‬ ‫ا‬ ‫ات‬ ‫ا‬‫ج‬ ‫أ‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أن‬ ‫و‬ ‫و‬ ‫روآ‬ ‫ه‬ ‫ا‬ ‫ط‬ ‫ء‬ ‫ا‬ ‫ا‬-‫ول‬ ‫ا‬-‫ا‬ ‫او‬‫از‬Hydroxyindole-O-methyl
  9. 9. transferase‫ت‬ ‫ا‬ ‫م‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ج‬ ‫ا‬ ‫ل‬ ‫ا‬‫ء‬ ‫ا‬ ‫ن‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ج‬ ‫أ‬‫ت‬ ‫آ‬ ‫از‬ ‫إ‬ ‫إ‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫و‬ ‫م‬ ‫وا‬ ‫ا‬ ‫ا‬‫را‬ ‫ا‬ ‫ة‬ ‫آ‬ ‫أ‬ ‫ت‬ ‫وآ‬....‫ت‬ ‫أ‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ط‬ ‫وا‬ ‫ة‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ث‬ ‫ا‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ه‬. -‫و‬ ‫ا‬ ‫ا‬Lymph nodes:‫و‬ ‫أو‬ ‫ج‬ ‫و‬ ‫ا‬ ‫ء‬ ‫أ‬"‫در‬Afferent ‫ووارد‬Efferent"‫ة‬ ‫آ‬ ‫آ‬ ‫أ‬ ‫و‬‫و‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫م‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬‫ر‬ ‫دة‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أ‬ ‫ده‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫د‬ ‫و‬ ‫ء‬...‫ا‬ ‫ق‬ ‫وا‬ ‫و‬ ‫ا‬ ‫أن‬ ‫ت‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬‫أو‬ ‫درة‬ ‫و‬ ‫أو‬ ‫واردة‬. ‫ا‬-‫وا‬-‫ا‬ ‫ء‬ ‫ا‬: ‫آ‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ن‬ ‫ذآ‬ ‫آ‬)(‫و‬)(‫ل‬ ‫ا‬ ‫ا‬)(٧٠%‫و‬)(٣٠...%‫ردر‬ ‫ه‬ ‫ة‬ ‫و‬‫ن‬)(٨٠%‫و‬ )(٢٠.. %‫ا‬ ‫ن‬ ‫ن‬ ‫ا‬ ‫ن‬ ‫ر‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫و‬)(٥٠%‫و‬)( ٥٠.% ‫ا‬‫ا‬-‫ا‬-‫ا‬‫ا‬-‫ا‬- ‫ل‬ ‫ا‬٣٠%٧٠%‫ا‬ ‫ز‬ ‫ا‬٥٠%٥٠% ‫ردر‬ ‫ه‬ ‫ة‬٨٠%٢٠%‫ر‬ ‫ا‬ ‫ز‬ ‫ا‬٥٠%٥٠% ‫ا‬٨٠%‫ا‬٢٠% ‫ر‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ر‬
  10. 10. -‫ا‬ ‫ا‬: ‫وه‬ ‫ا‬ ‫وا‬ ‫م‬ ‫ا‬ ‫ع‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫أه‬ ‫وا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ا‬‫ة‬ ‫آ‬ ‫اع‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬. ‫وه‬ ‫ر‬ ‫اع‬ ‫أ‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ا‬: ‫أو‬-‫اء‬ ‫ا‬ ‫م‬ ‫ا‬Avian red blood cells: ‫ا‬ ‫ع‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ع‬ ‫ا‬‫اة‬ ‫ي‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫أن‬Nucleated‫ا‬ ‫ع‬ ‫اة‬ ‫ر‬ ‫ا‬ ‫ده‬ ‫اوح‬ ‫و‬٢ ٥-٣‫ـ‬ ‫ا‬ ‫أو‬ ‫آ‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ن‬ Packed cell volume‫ا‬٣٠-٤٠‫ه‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫وأ‬٣٥‫ج‬ ‫ا‬‫و‬٣٥-٤٥ ‫و‬ ‫م‬ ‫ا‬٤٢‫و‬ ‫ا‬١٢٠‫ة‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ورة‬ ‫ا‬ ‫و‬ ‫ن‬ ‫ا‬ ‫ل‬. ‫ـ‬ ‫ا‬ ‫اءه‬ ‫أ‬ ‫ر‬ ‫اء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫اة‬ ‫د‬ ‫ا‬ ‫و‬Major histocompatibility complex- I‫أ‬ ‫و‬‫ا‬ ‫ا‬ ‫ن‬. -‫و‬ ‫ا‬Thrombocytes:‫ه‬‫ن‬ ‫آ‬ ‫و‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ده‬ ‫اوح‬ ‫و‬ ‫ذ‬ ‫ت‬ ‫ا‬ ‫أ‬ ‫اة‬ ‫و‬ ‫ا‬٢٥-٣٠‫أ‬ ‫وه‬ ‫م‬ ‫ا‬ ‫وا‬‫م‬ ‫ا‬ ‫ق‬ ‫ا‬ ‫ا‬ ‫ا‬‫ر‬ ‫ا‬ ‫ا‬ ‫و‬ ‫و‬ ‫و‬ ‫ا‬ ‫ا‬‫أ‬‫أ‬ ‫آ‬‫زم‬ ‫ا‬ ‫ن‬‫ن‬ ‫ا‬ ‫زرق‬ ‫ر‬ ‫ن‬ ‫ا‬ ‫دي‬ ‫ر‬ ‫و‬ ‫ن‬ ‫م‬ ‫ا‬ ‫ا‬ ‫و‬ ‫و‬ ‫و‬ ‫ا‬ ‫ا‬‫ا‬Phagocytosis ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫رك‬ ‫و‬...‫ا‬ ‫ا‬ ‫أن‬ ‫و‬. -‫ء‬ ‫ا‬ ‫م‬ ‫ا‬Avian leucocytes: ‫م‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ا‬ ‫ا‬‫ا‬ ‫د‬ ‫وا‬Total leucocytic count‫اوح‬١٦-٣٠ ‫م‬ ‫ا‬ ‫وا‬ ‫أ‬‫وه‬ ‫ر‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫و‬: ‫أ‬-‫ا‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬Granulocytic leucocytes: ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫زم‬ ‫ان‬ ‫وأ‬ ‫ل‬ ‫أ‬ ‫ذات‬ ‫ت‬ ‫د‬‫و‬ ‫م‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫د‬ ‫ا‬ ‫اوح‬ ‫و‬ ‫ا‬ ‫ورة‬Total granulocytic count٥-٧‫وا‬ ‫ف‬ ‫أ‬ ‫ا‬ ‫اع‬ ‫ا‬ ‫ه‬ ‫و‬ ‫وا‬ ‫ا‬ ‫و‬ ‫اة‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ة‬ ‫و‬:
  11. 11. ١-‫و‬ ‫ا‬Microphages=Heterophils: ‫ه‬‫ء‬‫ا‬ ‫دة‬‫ي‬Polymorphnuclear heterophilic granulocyte ‫ا‬ ‫و‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ا‬‫م‬ ‫ا‬ ‫ي‬ ‫إ‬ ‫و‬ ‫م‬ ‫ا‬ ‫ع‬ ‫ن‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫و‬١٢‫ه‬ ‫ل‬ ‫ة‬ ‫اوح‬ ‫و‬ ‫ا‬ ‫إ‬ ‫م‬ ‫ا‬ ‫ي‬ ‫در‬‫ة‬ ‫أآ‬‫م‬ ‫أ‬. ‫دا‬ ‫آ‬ ‫م‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ن‬‫ا‬‫ه‬١٢-١٥‫زم‬ ‫وا‬ ‫و‬ ‫و‬ ‫ا‬ ‫و‬ ‫وآ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫و‬ ‫ن‬ ‫ذات‬ ‫ت‬ ‫اءه‬ ‫ا‬ ‫ا‬‫ذات‬ ‫اة‬ ‫آ‬ ‫ا‬ ‫و‬ ‫أزرق‬ ‫ن‬ ‫ذو‬ ‫زم‬ ‫و‬ ‫ا‬ ‫ا‬...‫ر‬ ‫آ‬ ‫ا‬ ‫و‬ ‫م‬ ‫أ‬ ‫ي‬ ‫ا‬ ‫و‬ ‫وا‬ ‫آ‬ ‫د‬ ً‫ا‬ ‫وآ‬‫ت‬ ‫ا‬Ribosomes‫ز‬ ‫و‬ ‫وا‬Rough endoplasmic reticulum. ‫زم‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ن‬ ‫ه‬ ‫ا‬ ‫و‬: -‫ت‬ ‫ا‬ ‫ول‬ ‫ا‬ ‫ت‬ ‫ا‬Primary granules‫ة‬ ‫ت‬ ‫أ‬ ‫ي‬ ‫آ‬ ‫ت‬ ‫وه‬ bactericidal‫ا‬ ‫وآ‬ ‫ا‬Myeloproxidase. -‫ا‬ ‫ت‬ ‫ا‬Secondary granules‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ي‬‫آ‬Lactoferrin. ‫و‬ ‫وا‬‫ا‬‫ر‬ ‫ا‬ ‫ده‬ ‫اوح‬ ‫و‬ ‫ت‬ ‫ا‬ ‫و‬٤-٥‫ف‬ ‫أ‬‫أي‬ ‫ا‬٢٠-٣٠%‫وو‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ع‬ ‫أ‬ ‫وه‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫أ‬ ‫م‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ه‬ ‫ا‬Phagocytosis. ‫ر‬ ‫ن‬ ‫ا‬ ‫دا‬ ‫دة‬ ‫ا‬ ‫درة‬ ‫ا‬ ‫ود‬ ‫ون‬ ‫و‬ ‫ا‬ ‫ع‬ ‫در‬‫ت‬ ‫ود‬ ‫د‬ ‫م‬ ‫ا‬ ‫درة‬ ‫ن‬ ‫و‬ ‫ودة‬ ‫ا‬ ‫ا‬ ‫و‬ ‫م‬ ‫م‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫و‬ ‫ا‬‫ن‬ ‫آ‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ي‬ ‫ظ‬ ‫ا‬ ‫درة‬ ‫و‬ ً‫ا‬‫ر‬ ‫و‬ ‫ا‬ ‫م‬ ‫ا‬ ‫د‬ ‫و‬ ‫و‬‫ا‬ ‫ز‬ ‫ا‬ ‫أو‬ ‫آ‬ ‫ا‬ ‫اة‬ ‫ا‬ ‫ة‬ ‫و‬ ‫ا‬ ‫م‬‫اة‬ ‫ا‬ ‫دى‬ ‫أ‬(Mononuclear-phagocytic system) ‫ات‬ ‫ا‬ ‫اد‬ ‫م‬ ‫وب‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫و‬ ‫ا‬ ‫أن‬ ‫إ‬ ً‫ا‬ ‫و‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ت‬ ‫ا‬(Antigen-sensitive cells). ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬ ‫وا‬‫و‬‫ـ‬ ‫ا‬ ‫ت‬Cluster of differentiation = CD‫ا‬ ‫أه‬CD11a/CD18‫ا‬ ‫ا‬ ‫وا‬ ‫اة‬ ‫ا‬ ‫ات‬ ‫وو‬ ‫و‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫ي‬ ‫ا‬ ‫ى‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫وا‬‫و‬‫ـ‬ ‫ا‬CD11b/CD18‫ـ‬ ‫وا‬CD11c/CD18‫إ‬ ‫إ‬CD32‫ا‬ ‫ا‬‫ص‬Fc‫ا‬‫ـ‬ ‫وا‬ ‫د‬ ‫ا‬CD35‫ص‬ ‫ا‬ ‫ا‬C3b. ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ه‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫و‬Proteolytic enzymes ‫ء‬ ‫و‬ ‫ا‬ ‫ا‬ ‫وب‬ ‫ا‬ ‫و‬‫ر‬ ‫ا‬ ‫أو‬ ‫ت‬. ٢-‫ا‬Eosinophils:‫اة‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫ه‬Polymorphnuclear eosinophilic granulocyte‫ا‬ ‫ا‬ ‫و‬‫ن‬‫ا‬ ‫آ‬ ‫زم‬ ‫ا‬ ‫ا‬ ‫اء‬ ‫ا‬Eosin‫ة‬ ‫وه‬‫و‬ ‫ا‬ ‫وأآ‬ ‫اة‬ ‫ا‬‫و‬‫اوح‬١٢-١٧‫و‬ ‫ا‬ ‫ن‬ ‫دة‬ ‫و‬‫ا‬...‫ل‬ ‫ذات‬ ‫ا‬ ‫و‬ ‫آ‬ ‫ت‬ ‫زم‬ ‫ا‬ ‫ي‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ن‬ ‫ا‬Psittacine birds‫ا‬ ‫ه‬ ‫ن‬‫ت‬ ‫م‬ ‫ا‬ ‫ده‬ ‫اوح‬ ‫و‬ ‫أزرق‬ ‫ن‬ ‫ذات‬ ‫ز‬ ‫ا‬٠ ٥-١‫و‬ ‫وا‬ ‫أ‬ ١-٥%‫م‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أ‬. ‫و‬ ‫ل‬ ‫اآ‬ ‫ل‬ ‫ا‬ ‫إ‬ ‫و‬ ً ‫ر‬ ‫ا‬ ‫ع‬ ‫در‬ ‫ا‬ ‫وا‬ ‫ة‬ ‫ة‬ ‫م‬ ‫ا‬ ‫ي‬٤-٥‫داد‬ ‫و‬ ‫ا‬ ‫ا‬ ‫وه‬ ‫ج‬ ‫أن‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫وو‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫ان‬ ‫ا‬ ‫و‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا‬ ‫ده‬ Phagocytosis.
  12. 12. ‫و‬ ‫ودة‬ ‫رة‬ ‫و‬‫اة‬ ‫ا‬ ‫ات‬ ‫وو‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ات‬ ‫ت‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫آ‬ ‫آ‬ ‫ي‬ ‫و‬ ‫زوم‬ ‫ا‬ ‫ي‬ ‫و‬ ‫ا‬Acid phosphatase‫وآ‬ ‫وا‬Peroxidase‫أآ‬ ‫ا‬ ‫ا‬ ‫وآ‬ ‫و‬‫وآ‬ ‫ب‬ ‫ا‬ ‫وث‬ ‫ن‬ ‫ـ‬ ‫ا‬ ‫ا‬ ‫إزا‬ ‫ـ‬ ‫دور‬ ‫أن‬ ‫آ‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ة‬ ‫اع‬ ‫أ‬ ‫و‬ ‫ا‬. ٣-‫زو‬ ‫ا‬Basophils:‫اة‬ ‫ا‬ ‫ة‬ ‫ء‬Polymorphnuclear basophilic granulocyte cell‫ا‬ ‫ا‬ ‫و‬‫ن‬‫ا‬‫ا‬ ‫آ‬ ‫ا‬ ‫آ‬ ‫زم‬ ‫م‬ ‫ا‬ ‫ده‬ ‫اوح‬ ‫و‬ ‫ن‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫زم‬ ‫ا‬ ‫ي‬ ‫و‬٠ ٥-١‫أ‬ ‫و‬ ‫وا‬-٢%‫آ‬ ‫أ‬‫م‬ ‫ا‬ ‫ات‬‫ا‬ ‫ا‬ ‫وه‬ ‫ء‬ ‫ا‬‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ن‬ ‫و‬Phagocytosis. ‫ب‬-‫ا‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬Agranulocytic leucocytes: ‫ء‬ ‫دم‬ ‫ه‬‫ي‬‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ز‬ ‫ت‬ ‫زم‬ ‫ا‬‫ع‬ ‫ا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫م‬ ‫ا‬‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫وح‬Total agranulocytic count١١- ٢٣‫ا‬ ‫اع‬ ‫ا‬ ‫ه‬ ‫و‬ ‫وا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ة‬ ‫و‬ ‫وا‬ ‫أ‬: ١-‫ا‬Monocytes‫ج‬ ‫و‬ ‫آ‬ ‫وا‬"‫ة‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬"Macrophages: ‫م‬ ‫ا‬ ‫ع‬‫و‬‫ر‬ ‫م‬ ‫ده‬ ‫وو‬ ‫م‬ ‫ا‬ ‫ا‬‫أ‬‫ا‬‫و‬ ‫م‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫أ‬ ‫إ‬‫ل‬‫ات‬ ‫و‬‫اة‬ ‫ا‬‫ا‬‫أآ‬)‫اة‬ ‫ا‬ ‫ات‬ ‫و‬ ‫ا‬ ‫إ‬ ‫م‬ ‫ا‬ ‫ا‬ ‫أآ‬(‫و‬‫آ‬‫ة‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫دة‬ ‫ء‬ ‫أ‬‫ه‬Langerhan's cell‫و‬‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬Histocyte‫ي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬Microglia‫و‬‫ــــ‬‫ا‬‫ن‬‫آ‬ Von Kupffer cells‫و‬‫ـــ‬‫ا‬‫ـــ‬‫ا‬ ‫ا‬‫ا‬ ‫أو‬Alveolar macrophage or septal cell‫و‬‫ا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ي‬ ‫ا‬ ‫ات‬ ‫و‬‫آ‬ ‫ا‬ ‫ات‬ ‫ا‬ ‫ز‬Monocyte- macrophage system‫ا‬ ‫ز‬ ‫ف‬ ‫ن‬ ‫وآ‬‫ا‬Reticuloendothelial system. ‫اوح‬ ‫و‬٢٥-٥٠‫ون‬‫د‬ ‫و‬‫ه‬‫ا‬ ‫م‬ ‫ا‬١ ٥‫أ‬ ‫وا‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ا‬٥%‫ي‬ ‫و‬ ‫ا‬ ‫أن‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ق‬ ‫وا‬ Smooth contour‫آ‬ ‫اءات‬ ‫ي‬ ‫ا‬ ‫أ‬‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ه‬ ‫ة‬ ‫ة‬ ‫آ‬ ‫ا‬ ‫ط‬ ‫ارا‬ ‫ر‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫و‬‫ا‬ ‫م‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ة‬ ‫وا‬ ‫ة‬. ‫وه‬‫ا‬ ‫ة‬‫و‬‫ا‬ ‫و‬ ‫ا‬ ‫ر‬‫أ‬ ‫رة‬ ‫ا‬‫أو‬ ‫أي‬ ‫ل‬ ‫واد‬ ‫م‬ ‫وآ‬ ‫ا‬ ‫و‬ ‫ت‬ ‫و‬‫ا‬ ‫ـ‬‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫ة‬ ‫ا‬ ‫ء‬ ‫وأ‬ ‫ت‬ ‫أي‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ه‬ ‫وا‬ ‫و‬ ‫ت‬ ‫و‬ ‫ت‬ ‫آ‬‫زا‬ ‫ا‬ ‫م‬ ‫ه‬ ‫ء‬ ‫ا‬ ‫ت‬. ‫ات‬ ‫و‬ ‫ا‬ ‫و‬‫د‬ ‫ا‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ت‬ ‫ت‬ ‫وا‬ ‫اة‬ ‫ا‬Fc‫رة‬ ‫و‬ ‫ع‬ ‫ا‬IgY‫ا‬ ‫ا‬ ‫وآ‬C3b‫ا‬ ‫ع‬ ‫وا‬‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬(MCH class II). ‫و‬ ‫أه‬ ‫و‬‫ه‬‫ا‬: -‫ا‬ ‫أو‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫وإزا‬ ‫ه‬ ‫و‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫م‬ ‫ا‬‫ت‬. -‫ا‬ ‫ت‬ ‫ا‬ ‫ده‬ ‫و‬ ‫و‬ ‫أ‬ ‫آ‬Chronic inflammations. -‫ا‬ ‫ض‬ ‫و‬Ag presenting & processing‫ا‬ ‫ا‬ ‫اث‬. -‫ا‬ ‫ا‬‫ت‬ ‫آ‬ ‫ا‬ ‫از‬ ‫ا‬‫آ‬ ‫ا‬-١Interleukin-1‫ي‬ ‫ا‬ ‫ا‬-‫آ‬ ‫ا‬ ‫ز‬-٢‫ون‬ ‫ا‬ ‫از‬ ‫م‬ ‫آ‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ء‬ ‫ل‬ ‫ا‬.
  13. 13. ٢-‫و‬ ‫ا‬ ‫ا‬tesLymphocy: ‫ا‬ ‫ا‬ ‫ء‬ ‫ه‬‫أ‬ ‫و‬ ‫ا‬ ‫وآ‬ ‫ا‬ ‫وا‬ ‫م‬ ‫ا‬ ‫ع‬ ‫رة‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ه‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ات‬ ‫ا‬ ‫ا‬Self‫ات‬ ‫ا‬ ‫و‬Non-self‫ا‬ ‫آ‬ ‫ا‬ ‫وآ‬Immune memory‫دم‬ ‫ده‬ ‫اوح‬ ‫و‬ ‫ر‬ ‫ا‬١٠-١٢‫ا‬ ‫ة‬ ‫ه‬ ‫و‬ ‫م‬ ‫ا‬ ‫و‬ ‫أ‬٢٠-٤٥%‫أ‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬. ‫آ‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫د‬ ‫وو‬)‫ا‬ ‫م‬ ‫وا‬ ‫وا‬ ‫ا‬‫ر‬ ‫ا‬ ‫ز‬ ‫وا‬ ‫ل‬ ‫وا‬ ‫ه‬ ‫و‬‫وا‬ ‫ء‬ ‫ا‬(‫و‬ ‫أ‬ ‫و‬ ‫و‬ ‫د‬ ‫و‬ ‫إ‬ ‫دي‬ ‫ا‬ ‫رات‬ ‫أ‬ ‫ر‬ ‫أن‬ ‫ا‬ ‫ة‬ ‫وا‬ ‫أ‬ ‫ر‬ ‫وأ‬ ‫و‬ ‫ت‬ ‫ا‬ ‫إ‬ ‫دي‬ ‫ا‬ ‫ا‬‫وو‬ ‫آ‬. ‫و‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ن‬ ‫و‬-T-Lymphocytes‫و‬ ‫ا‬ ‫وا‬-B-Lymphocytes‫ا‬ ‫وه‬ ‫ره‬ ‫ا‬ ‫و‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫ت‬ ‫ا‬ ‫ا‬‫أ‬ ‫إ‬ ‫إ‬ ‫وا‬ ‫ات‬ ‫وا‬‫آ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ا‬ ‫ض‬ ‫و‬: i-‫و‬ ‫ا‬ ‫ا‬)(Lymphocytes-T: ‫س‬ ‫ا‬ ‫ة‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫وآ‬ ‫ا‬ ‫وا‬ ‫م‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ه‬"‫وا‬"‫و‬٧٠-٨٠%‫دا‬ ‫وه‬ ‫م‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫وا‬ ‫م‬ ‫ا‬ ‫وران‬ ‫ا‬‫وه‬ ‫ا‬ ‫ر‬ ‫ـ‬‫ـ‬ ‫ـ‬ ‫ة‬ ‫ـ‬ ‫ـ‬ ‫ـ‬‫وه‬ ‫ت‬ ‫أ‬ ‫أي‬ ‫ــ‬ ‫ا‬ ‫ــ‬ ‫ا‬‫ـــ‬‫ـ‬ ‫ا‬‫ــ‬‫ا‬‫ـ‬‫ـ‬Cell-mediated Immunity‫ه‬ ‫و‬‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ادا‬ ‫أ‬ ‫و‬ ‫و‬-‫ا‬Sensitized T-cells‫دل‬ ‫ور‬ ‫ة‬ ‫ذاآ‬ ‫آ‬ ‫ا‬ ‫د‬ ‫و‬ ‫ا‬ ‫ا‬ ‫دور‬ ‫م‬ ‫وا‬ ‫ا‬. ‫ا‬ ‫و‬-‫ا‬ ‫ف‬ ‫ا‬ ‫إ‬Subpopulation‫ا‬ ‫ت‬ ‫وا‬ ‫ا‬ ‫دا‬ ‫ا‬ ‫دة‬ ‫ا‬‫ا‬ ‫م‬ ‫و‬-‫و‬ ‫ا‬ ‫أ‬ ‫و‬‫أو‬ ‫و‬ ‫و‬ ‫ى‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬B and T cellRegulatory Function‫وا‬‫ة‬ ‫و‬Effector Function‫و‬‫آ‬ ‫ا‬ ‫ج‬ ‫إ‬ ‫وآ‬ ‫ا‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ا‬ Lymphokines‫و‬‫ا‬-‫ت‬ ‫ا‬ ‫وه‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ة‬ ‫إ‬ ‫ه‬: -CD2‫م‬ ‫اء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ت‬ ‫ص‬ ‫ا‬ ‫ا‬Sheep red blood cell = SRBC‫و‬‫ه‬ ‫ا‬ ‫اع‬ ‫أ‬-‫ا‬ ‫و‬-‫و‬ ‫ت‬ ‫ا‬ ‫ن‬ ‫م‬ ‫اء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫ي‬ ‫ه‬ ‫ا‬ ‫ا‬Rosettes. -CD3‫ا‬ ‫ت‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫ه‬-. CD4-‫ا‬ ‫ا‬ ‫ه‬‫ا‬(MHC class-II)‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬. CD8-‫ول‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬(MHC class-I)‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬. ‫ف‬ ‫أ‬ ‫و‬‫ا‬-‫اع‬ ‫وا‬ ‫ت‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫د‬‫ا‬-‫ه‬: -‫ا‬-‫ة‬ ‫ا‬Helper Cells-T:‫ف‬ ‫ا‬ ‫ا‬ ‫ورآ‬ ‫ا‬ ‫د‬ ‫ي‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ه‬‫أو‬ ‫ء‬ ‫آ‬ ‫أو‬ ‫ا‬ ‫اء‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫وس‬ ‫ا‬ ‫ا‬‫ل‬ ‫أ‬ ‫آ‬ ‫ا‬‫ا‬ ‫ز‬ ‫ا‬. ‫ا‬ ‫د‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ه‬ ‫و‬CD2, CD3, CD4‫ا‬ ‫ن‬ ‫أي‬ ‫أ‬CD4 ‫و‬‫ا‬ ‫دات‬ ‫ا‬Epitopes‫ت‬ ‫و‬‫ت‬ ‫ا‬ ‫أو‬‫ر‬ ‫ا‬Exogenous Antigens‫ون‬ ‫ـ‬ ‫ا‬MHC-II. ‫ا‬ ‫ا‬ ‫وه‬‫وه‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫إ‬ ‫و‬:
  14. 14. -‫آ‬ ‫ا‬-٢‫ا‬ ‫ور‬ ‫م‬ ‫ي‬ ‫ا‬‫ل‬ ‫ا‬‫ا‬-‫م‬ ‫ا‬ ‫ج‬ ‫إ‬‫و‬ ‫دة‬ ‫ا‬ ‫ا‬-‫ا‬ ‫ا‬ ‫اث‬ ‫أ‬ ‫ة‬ ‫ا‬‫ت‬ ‫ا‬ ‫م‬ ‫وأ‬ ‫ا‬. -‫وه‬ ‫ون‬ ‫ا‬‫ي‬ ‫و‬Glycoprotein‫رض‬‫و‬‫ا‬ ‫دا‬ ‫ا‬ ‫ر‬ ‫و‬ ‫وس‬ ‫ا‬ ‫ورة‬ ‫ا‬‫ا‬‫آ‬‫ت‬ ‫و‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫و‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬. -‫ا‬-‫ا‬Cytotoxic Cells-T:‫و‬‫ا‬ ‫دورا‬‫ا‬ ‫ا‬‫ت‬ ‫و‬ ‫و‬ ‫ا‬ ‫وا‬‫آ‬‫ا‬ ‫ا‬ ‫ر‬‫رو‬‫ت‬ ‫د‬ ‫و‬ ‫ا‬CD2 CD3 CD8 ‫ا‬ ‫ن‬ ‫أي‬ ‫أ‬CD8‫و‬‫ا‬ ‫دات‬ ‫ا‬Epitopes‫ت‬‫ا‬ ‫ا‬ Endogenous Antigens‫ـ‬ ‫ا‬ ‫ون‬MHC-I. -‫ا‬-‫ا‬ ‫أو‬ ‫ا‬Suppressor Cells-T:‫آ‬ ‫ا‬ ‫ج‬ ‫م‬-٢‫ا‬ ‫وه‬‫ا‬ ‫ا‬ ‫ط‬ ‫آ‬ ‫ا‬ ‫ة‬ ‫ه‬-‫ج‬ ‫إ‬‫ا‬‫م‬‫ا‬ ‫ط‬ ‫وآ‬ ‫دة‬ ‫ا‬-‫ة‬ ‫ه‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫د‬ ‫ا‬CD2 CD3 CD8‫ن‬ ‫أي‬‫ا‬CD8‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ه‬ ‫وث‬ ‫ا‬ ‫أ‬ ‫ا‬Immunological Tolerance ‫ت‬ ‫ا‬. -‫ا‬-‫ة‬ ‫ا‬Cell-Delayed T:‫د‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أه‬4-CD‫درا‬ ‫و‬ ‫د‬ ‫ا‬CD-8‫ا‬ ‫دات‬ ‫ا‬ ‫و‬Epitopes‫ـ‬ ‫ا‬ ‫ون‬MHC-2‫ـ‬ ‫ا‬ ‫أ‬ ‫أ‬ ‫و‬ MHC-1‫و‬‫ت‬ ‫آ‬Lymphokines‫ا‬ ‫ب‬ ‫ا‬ ‫ت‬ ‫ج‬ ‫و‬ ‫آ‬. -‫ا‬-‫ة‬ ‫اآ‬ ‫ا‬cells-Memory T:‫د‬ ‫ا‬4-CD‫و‬‫آ‬8-CD‫و‬‫اآ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬‫ة‬ ‫ي‬ ‫أ‬ ‫ات‬ ‫أو‬ ‫ة‬ ‫ا‬ ‫و‬ ‫وب‬ ‫أي‬ ‫ا‬. ii-‫و‬ ‫ا‬ ‫ا‬)(Lymphocytes-B:‫ع‬ ‫ع‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ر‬ ‫ا‬ ‫ن‬ ‫ه‬ ‫ا‬ ‫ه‬ ‫و‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫وآ‬ ‫ا‬ ‫وا‬ ‫م‬ ‫ا‬ urosopoetin‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬-٤‫آ‬ ‫وا‬-٥‫ز‬ ‫ي‬ ‫ا‬‫ا‬- ‫ا‬ ‫ة‬ ‫ا‬Activated T-helper‫ا‬ ‫ة‬ ‫ه‬ ‫و‬‫وا‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ز‬ ‫وا‬ ‫ردر‬ ‫ه‬ ‫ة‬ ‫ر‬ ‫ا‬. ‫ا‬ ‫ة‬ ‫ه‬ ‫و‬١٥-٢٠%‫ر‬ ‫ا‬ ‫ة‬ ‫آ‬ ‫وه‬ ‫م‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬- ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬"٥-٧‫م‬ ‫أ‬"‫ا‬ ‫ا‬ ‫رن‬ ‫اذا‬-"‫ا‬ ‫ر‬." ‫ا‬-‫ت‬ ‫د‬‫وه‬‫ت‬‫د‬ ‫ع‬ ‫ا‬ ‫ا‬Primitive IgD‫ـ‬ ‫ا‬ ‫ت‬ ‫ا‬Cluster of differentiation = CD‫وه‬ ‫دة‬ ‫ا‬ ‫ي‬ ‫و‬Glycoprotein‫ا‬-‫ت‬ ‫ا‬ ‫و‬CD19 + CD20 + CD21‫وآ‬ ‫وا‬ ‫دة‬ ‫ا‬ ‫ت‬‫آ‬ ‫ا‬‫وأ‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬C4b+C3b+C1q‫ـ‬ ‫ص‬ ‫ا‬ ‫وا‬Fc‫ا‬IgG. ‫ا‬ ‫أن‬ ‫و‬-‫ا‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫وا‬ ‫ات‬ ‫ا‬ ‫ا‬‫دا‬ ‫ا‬ ‫إ‬ ‫ا‬‫ا‬Ig‫ك‬ ‫و‬ ‫ز‬ ‫ي‬ ‫ا‬Bα‫ز‬ ‫ا‬IgG‫و‬Bγ‫ا‬ ‫ز‬IgM‫و‬Bµ‫ز‬ ‫ا‬IgE‫و‬Bε‫ز‬ ‫ا‬IgD‫و‬Bδ‫ز‬ ‫ا‬IgA ‫و‬‫ا‬ ‫ا‬ ‫ا‬ ‫أن‬ ‫م‬ ‫ا‬-IgG‫و‬IgM‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬-IgA.. ‫وه‬‫ا‬ ‫ا‬ ‫ا‬ ‫أي‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ج‬ ‫إ‬Antibody-mediated Immunity ‫إ‬ ‫و‬ ‫و‬ ‫ا‬‫ز‬ ‫ا‬plasma cells‫ا‬‫دة‬ ‫ا‬ ‫م‬
  15. 15. ‫ه‬ ‫ة‬ ‫ذاآ‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ل‬ ‫و‬‫و‬‫ر‬ ‫ا‬ ‫ث‬‫و‬‫ض‬ ‫ا‬ ‫ل‬ ‫ى‬ ‫أ‬ ‫ة‬ ‫ا‬. ‫ث‬ ‫واذا‬-‫آ‬ ‫ا‬ ‫أو‬ ‫ت‬ ‫ا‬-٢‫م‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ل‬ ‫م‬ ‫دة‬ ‫ا‬‫ا‬ ‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫و‬ ‫وي‬ ‫ا‬ ‫وا‬ ١٣ ١٠B-cell clones‫و‬ ‫ت‬ ‫ا‬ ‫ع‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫وآ‬ ‫ت‬Fc receptor‫د‬ ‫ع‬ ‫ا‬ ‫ا‬ ‫د‬ ‫رة‬Primitive IgD‫ا‬ ‫ه‬ ‫ف‬ ‫و‬ ‫أ‬ ‫أي‬ ‫ا‬‫ا‬ ‫ا‬Clone selection‫ا‬ ‫ا‬ ‫ه‬ Clone proliferation or expansion‫ز‬ ‫ا‬ ‫ل‬Clone transformation‫م‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ج‬ ‫ز‬ ‫ا‬‫و‬ ‫ا‬‫ا‬-‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫آ‬ ‫آ‬ ‫أ‬ ‫و‬ ‫ا‬C3 receptor‫أي‬ ‫ا‬ ‫ة‬ ‫اآ‬ ‫ا‬ ‫ة‬ ‫ذاآ‬ ‫ا‬ ‫ل‬ ‫و‬ ‫ي‬ ‫أ‬ ‫ات‬ ‫أو‬ ‫ة‬ ‫ا‬ ‫و‬ ‫وب‬. iii-‫ز‬ ‫ا‬Plasma Cells:‫ا‬-‫ا‬‫أو‬ ‫ة‬‫ة‬ ‫آ‬-٢‫ا‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫و‬morphology‫ا‬- ‫ز‬ ‫و‬ ‫ز‬ ‫ا‬ ‫وا‬plasmablasts‫ا‬‫و‬ ‫ا‬ ‫ء‬ ‫ا‬‫ا‬ ‫ا‬ ‫ون‬ ‫ا‬-‫وا‬-‫ء‬ ‫ا‬ ‫ز‬ ‫ـ‬ ‫ا‬ ‫و‬mantle zone‫أن‬ ‫و‬ ‫ل‬ ‫ا‬ ‫إ‬ ‫ر‬‫د‬ ‫آ‬ ‫ز‬‫ة‬‫ء‬ ‫أ‬ ‫زع‬ ‫ا‬‫أآ‬ ‫و‬ ‫ا‬ ‫و‬ ‫ل‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫د‬‫ر‬ ‫ا‬ ‫ز‬ ‫وا‬ ‫ردر‬ ‫ه‬ ‫ة‬. ‫ز‬ ‫ا‬ ‫و‬‫ا‬ ‫و‬Ovoid cells‫ه‬٨-٩‫ي‬ ‫آ‬ ‫دا‬ ‫اة‬ ‫و‬ ‫و‬ ‫و‬ ‫آ‬‫م‬ ‫ا‬ ‫زع‬Unevenly distributed chromatin‫ز‬ ‫و‬ ‫ا‬ ‫آ‬ Rough endoplasmic reticulum‫ا‬ ‫ت‬ ‫ة‬basic dyes‫و‬ ‫وا‬Pyronin‫و‬ ‫ر‬ ‫ة‬ ‫ز‬ ‫ا‬‫وا‬ ‫ا‬ ‫ع‬ ‫أي‬ ‫ن‬ ‫أ‬ ‫أي‬ ‫آ‬ ‫اوح‬ ‫ة‬ ‫ات‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ا‬٣-٤‫ا‬ ‫و‬ ‫م‬ ‫أ‬‫ة‬ ٣-٤‫أ‬. ‫و‬‫ه‬‫درة‬٣٠٠‫يء‬‫دة‬ ‫ا‬ ‫م‬ ‫وا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ت‬ ‫ا‬Polyribosomes‫ا‬ ‫ز‬ ‫و‬ ‫ا‬ ‫ز‬‫ا‬‫ن‬ ‫آ‬ ‫د‬ ‫ن‬ ‫ا‬. ‫ت‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫وا‬-‫ذات‬-‫و‬ ‫م‬ ‫ا‬ ‫ا‬ ‫رة‬ ‫أ‬ ‫ز‬ ‫ا‬ ‫أن‬-‫ي‬ ‫و‬‫ي‬ ‫أ‬ ‫أ‬ ‫دة‬ ‫م‬ ‫أ‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫ت‬ ‫ا‬‫ا‬-‫ة‬ ‫وذاآ‬ ‫ز‬ ‫إ‬ ‫ره‬. iv-‫ا‬ ‫ا‬Killer cells:‫و‬ ‫ا‬ ‫ا‬ ‫ه‬‫ا‬ ‫اث‬ ‫أ‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫م‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ك‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ة‬ ‫ا‬Antibodies-Dependent Cell-Mediated Cytotoxcity (ADCC). v-‫ا‬ ‫ا‬ ‫ا‬=Natural killer cells:‫أآ‬ ‫ة‬ ‫آ‬ ‫و‬ ‫ه‬٣-٥% ‫و‬ ‫ا‬ ‫ا‬ ‫ع‬‫ا‬ ‫ا‬ ‫ورة‬ ‫ا‬‫ع‬ ‫د‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ة‬ ‫وه‬ ‫م‬ ‫ا‬‫ر‬‫ا‬ ‫ا‬ ‫و‬-‫ا‬ ‫و‬-Non-B-Non-T Cells‫ـ‬ ‫ة‬ ‫ه‬ ‫آ‬ ‫ت‬ ‫ي‬Null Cells‫أ‬ ‫آ‬‫إ‬ ‫ج‬ ‫و‬ ‫رة‬ ‫ن‬‫ط‬ ‫ار‬ ‫د‬ ‫و‬MHC class-I‫أو‬MHC class-II‫م‬.
  16. 16. ‫ذات‬ ‫وه‬‫ا‬ ‫و‬-‫ا‬T-cytotoxic cells‫ا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬‫ي‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫م‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬(ADCC)‫ا‬ ‫اع‬ ‫أ‬ ‫د‬ ‫ط‬ ‫أن‬ ‫و‬ Staphylococcus aureus‫و‬Salmonella typhimurium‫أ‬ ‫وأ‬ ‫ت‬ ‫ا‬ ‫و‬‫اث‬ ‫ي‬Perforation‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ار‬‫ر‬ ‫ا‬"‫ا‬ ‫و‬ ‫ا‬" Perforin‫و‬‫ون‬ ‫و‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ا‬Interferon-α ‫آ‬ ‫أ‬ ‫ون‬-٢‫ون‬ ‫ا‬ ‫و‬Interferon-α‫ن‬ ‫ز‬ ‫ا‬ ‫وا‬Tumor necrosis factor =. vi-‫ة‬ ‫اآ‬ ‫ا‬Memory Cells:‫ا‬ ‫ا‬ ‫ن‬ ‫ك‬ ‫ه‬-‫ع‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫وا‬ ‫ة‬ ‫اآ‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ع‬ ‫وا‬ ‫ز‬ ‫ا‬ ‫ه‬ ‫ول‬ ‫ا‬‫إ‬ ‫و‬ ‫ا‬ ‫ا‬‫ا‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ذات‬ ‫إ‬ ‫ض‬ ‫ا‬-‫و‬ ‫إ‬ ‫ا‬‫ة‬ ‫اآ‬ ‫ا‬ ‫ا‬ ‫إ‬-‫ا‬ ‫ى‬ ‫أ‬ ‫اع‬ ‫أ‬ ‫ا‬ ‫إ‬ ‫أو‬ ‫ز‬ ‫ا‬ ‫أ‬ ‫ا‬-‫ة‬ ‫اآ‬ ‫ا‬ ‫و‬ ‫ز‬ ‫ا‬‫ة‬ ‫و‬ ‫و‬...‫وي‬ ‫ا‬ ‫ار‬ ‫و‬ ‫و‬ ‫أ‬ ‫اث‬ ‫وأ‬ ‫م‬ ‫ا‬ ‫اء‬ ‫ة‬ ‫اآ‬ ‫ا‬ ‫ن‬ ‫د‬ ‫و‬ ‫و‬ ‫ا‬ ‫ات‬ ‫د‬ ‫و‬ ‫إ‬ ‫ه‬ ‫ج‬ ‫و‬ ‫و‬‫آ‬ ‫ا‬-١‫آ‬ ‫وا‬-٥‫ا‬ ‫وآ‬‫ا‬ ‫ن‬. ‫آ‬ ‫ة‬ ‫اآ‬ ‫ا‬ ‫ت‬ ‫و‬-‫ا‬ ‫وه‬ ‫داد‬ ‫اه‬ ‫و‬ ‫م‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ن‬Somatic mutation‫اد‬ ‫وأ‬‫ء‬ ‫وا‬ ‫ل‬ ‫ا‬ ‫در‬ ‫ة‬ ‫اآ‬ ‫ا‬ ‫ة‬ ‫آ‬ ‫ا‬ ‫و‬ ‫م‬ ‫ا‬ ‫ع‬ ‫إ‬ ‫ا‬‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ر‬ ‫أه‬ ‫م‬ ‫ا‬ ‫ع‬. ‫ا‬ ‫ا‬Immunocompetence:‫ا‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫أن‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ات‬ ‫أ‬ ‫و‬ ‫ل‬ ‫ا‬ ‫ي‬ ‫ه‬ ‫ذ‬‫ا‬ ‫ا‬ Immuneocompetent cells‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫اث‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ه‬: ‫ول‬ ‫ا‬-‫ا‬ ‫ا‬:‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫وه‬"‫زو‬ ‫وا‬ ‫وا‬ ‫و‬ ‫ا‬"‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫وآ‬. ‫ا‬-‫و‬ ‫ا‬ ‫ا‬:‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫وا‬ ‫ع‬ ‫وا‬ ‫ع‬. ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬: -‫آ‬ ‫ا‬ ‫ا‬:‫ا‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫وه‬"‫زو‬ ‫وا‬ ‫وا‬ ‫و‬ ‫ا‬"‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬. -‫ا‬ ‫ا‬Antigen processing:‫وا‬ ‫ا‬ ‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫وه‬-. -‫ا‬ ‫ا‬Regulator cells:‫ا‬-‫ة‬ ‫ا‬Helper T-cells‫ا‬ ‫و‬Suppressor T- cells. -‫ا‬ ‫ا‬Effector cells:‫ا‬-‫ا‬Cytotoxic T-cells‫و‬‫ة‬ ‫ا‬Delayed T-cells. -‫ا‬ ‫م‬ ‫زة‬ ‫ا‬ ‫ا‬:‫ا‬-B-Lymphocytes‫ز‬ ‫ا‬ ‫و‬. -‫ا‬ ‫ا‬Avian Cytokines: ‫ا‬ ‫ا‬‫ز‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ع‬ ‫ه‬‫ا‬-‫وا‬-‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬‫آ‬ ‫آ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫وا‬Chemical messengers‫آ‬ ‫رات‬ ‫أ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ا‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ا‬‫ا‬ ‫و‬٩٠‫ا‬ ‫ن‬ ‫ا‬ ‫وف‬ ‫ع‬ ‫ا‬ ‫وأه‬ ‫ا‬:
  17. 17. -‫ون‬ ‫ا‬Interferon-α:‫ي‬ ‫و‬Glycoprotein‫أي‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫رض‬ ‫رض‬‫و‬‫ا‬ ‫ر‬ ‫و‬ ‫وس‬ ‫ا‬‫ا‬ ‫ورة‬ ‫ا‬ ‫ا‬ ‫دا‬ ‫و‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬ ‫و‬ ‫وا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ز‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫وس‬ ‫ا‬ ‫ات‬ ‫ا‬ ‫وس‬ ‫ا‬ ‫ورة‬ ‫ا‬ ‫ا‬)‫ا‬ ‫ا‬ ‫أي‬ (‫ا‬ ‫ل‬‫ا‬ ‫دا‬ ‫وس‬ ‫ا‬ ‫خ‬)‫و‬ ‫ا‬ ‫وي‬ ‫ا‬ ‫ا‬ ‫أي‬(‫رة‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬Intercellular parasites‫ا‬ ‫أو‬‫ـ‬ ‫ا‬Chlamydiae‫و‬‫ـ‬ ‫ا‬ ‫أ‬Rickettsiae ‫ـ‬ ‫ا‬ ‫زوا‬ ‫و‬ ‫وا‬Toxoplasma‫ا‬ ‫وا‬‫ـ‬ ‫ا‬Streptococci‫و‬‫آ‬Staphylococci‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬endotoxins‫و‬‫ا‬ ‫د‬ ‫آ‬ ‫ز‬ ‫وإ‬ ‫وس‬. ‫وس‬ ‫و‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬Species specific and not virus specific. ‫ا‬ ‫آ‬ ‫و‬ ‫ا‬ ‫أ‬ ‫و‬-)Inhibition of B-cell activation(‫رة‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬)Enhancement of the cytotoxic activity of natural Killer cells(‫و‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫و‬ ‫ا‬ ‫أو‬ ‫ارة‬"‫و‬ ‫و‬ ‫أ‬"‫ه‬ ‫ا‬ ‫ا‬ ‫وأه‬ ‫ا‬‫ا‬ ‫ز‬ ‫ي‬ ‫ا‬ ‫ون‬-‫ي‬ ‫ا‬ ‫و‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬. -‫آ‬ ‫ا‬-١Interleukin-1:‫ا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ز‬-‫ة‬ ‫ا‬‫و‬‫ا‬ ‫ا‬ Fever‫ا‬ ‫ا‬ ‫و‬ ‫ا‬‫آ‬. -‫آ‬ ‫ا‬-٢Interleukin-2:‫ا‬ ‫ز‬-‫ا‬ ‫و‬ ‫أ‬ ‫و‬ ‫ة‬ ‫ا‬-‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫وا‬. -‫آ‬ ‫ا‬-٣Interleukin-3:‫ا‬ ‫ز‬-‫آ‬ ‫ا‬ ‫ا‬ ‫م‬ ‫أ‬ ‫و‬ ‫ة‬ ‫ا‬‫ج‬ ‫أ‬ ‫ء‬ ‫وا‬ ‫اء‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬. -‫آ‬ ‫ا‬-٤‫و‬٥Interleukin-4 & 5:‫ا‬ ‫ز‬-‫ا‬ ‫و‬ ‫ة‬ ‫ا‬-‫م‬ ‫ا‬ ‫ج‬ ‫دة‬ ‫ا‬. -‫آ‬ ‫ا‬-٦Interleukin-6:‫ا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ز‬-‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫از‬ ‫أ‬. -‫ا‬‫آ‬-٧Interleukin-7:‫ـ‬ ‫ا‬ ‫ز‬Stroma‫ا‬-‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫از‬ ‫أ‬. -‫آ‬ ‫ا‬-٨Interleukin-8:‫ا‬ ‫ب‬ ‫ا‬ ‫و‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫ز‬Chemotaxis ‫و‬. -‫آ‬ ‫ا‬-١٢‫و‬١٨Interleukin-12 & 18:‫و‬ ‫آ‬ ‫ا‬ ‫ز‬‫ا‬ ‫وا‬ ‫ج‬‫وا‬-‫و‬ ‫ا‬-‫آ‬ ‫ة‬ ‫ا‬‫أن‬‫آ‬ ‫ا‬-١٨‫ون‬ ‫ا‬ ‫از‬ ‫أ‬. -‫ن‬ ‫ز‬ ‫ا‬ ‫ا‬Tumor necrosis factor:‫ه‬ ‫أ‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫وا‬-‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬‫وا‬-.
  18. 18. ‫ا‬ ‫ا‬ ‫أه‬ ‫ول‬: ‫ا‬ ‫ا‬‫از‬ ‫ا‬ ‫ر‬‫ا‬ ‫ف‬ ‫ون‬ ‫ا‬Interferon-α‫ا‬-‫ة‬ ‫ا‬ ‫ا‬ ‫آ‬-‫ا‬ ‫رة‬ ‫ا‬ ‫و‬ ‫و‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬‫ت‬ ‫و‬ ‫ا‬ ‫ي‬. ‫آ‬ ‫ا‬-١Interleukin-1‫ج‬ ‫و‬ ‫آ‬ ‫ا‬‫ا‬-‫ة‬ ‫ا‬. ‫آ‬ ‫ا‬-٢Interleukin-2‫ا‬-‫ة‬ ‫ا‬ ‫ا‬ ‫م‬ ‫أ‬-‫وا‬ ‫ة‬ ‫ا‬- ‫وا‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬. ‫آ‬ ‫ا‬-٣Interleukin-3 ‫ا‬-‫ة‬ ‫ا‬‫و‬ ‫ج‬ ‫أ‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫م‬ ‫أ‬ ‫ء‬ ‫وا‬ ‫اء‬ ‫ا‬ ‫ا‬ ‫ا‬. ‫آ‬ ‫ا‬-٤‫و‬٥Interleukin-4 & 5 ‫ا‬-‫ة‬ ‫ا‬‫ا‬-‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ج‬. ‫آ‬ ‫ا‬-٦Interleukin-6‫ج‬ ‫و‬ ‫آ‬ ‫ا‬‫ا‬-‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫از‬ ‫أ‬. ‫آ‬ ‫ا‬-٧Interleukin-7‫ـ‬ ‫ا‬Stroma‫ا‬-‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫از‬ ‫أ‬. ‫آ‬ ‫ا‬-٨Interleukin-8 ‫ا‬- ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫ب‬ ‫ا‬Chemotaxis‫و‬. ‫آ‬ ‫ا‬-١٢‫و‬١٨Interleukin-12 & 18 ‫ا‬‫وا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬‫وا‬-. ‫ا‬-‫ون‬ ‫ا‬ ‫از‬ ‫أ‬ ‫و‬ ‫ة‬ ‫ا‬ . ‫ن‬ ‫ز‬ ‫ا‬ ‫ا‬Tumor necrosis factor ‫ة‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫م‬ ‫أ‬- ‫وا‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬-.
  19. 19. ‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ر‬ ‫و‬ ‫ة‬:
  20. 20. ‫ا‬ ‫اع‬ ‫أ‬ Types of Immunity ‫ا‬ ‫ا‬ ‫ة‬ ‫وآ‬ ‫أ‬ ‫رة‬ ‫ه‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ى‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫و‬ ‫إن‬ ‫وا‬ ‫ا‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫وي‬ ‫ا‬ ‫و‬ ‫أ‬‫ء‬. ‫ر‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ى‬ ‫ر‬ ‫ا‬ ‫ه‬ ‫ر‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ى‬ ‫ا‬ ‫ا‬ ‫أن‬ ‫و‬ ‫ن‬ ‫وا‬ ‫ت‬ ‫وا‬ ‫ر‬ ‫ا‬.....‫ه‬ ‫أ‬ ‫ا‬ ‫و‬: -‫رو‬ ‫ا‬ ‫ا‬ ‫ا‬:‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ا‬‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ا‬ ‫و‬ ‫اث‬ ‫أ‬ ‫دا‬ ‫وا‬ ‫ا‬ ‫ذن‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫وه‬ ‫ء‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ل‬ ‫د‬ ‫ول‬ ‫أي‬ ‫أو‬ ‫وب‬ ‫أي‬ ‫و‬ ‫و‬ ‫رب‬ ‫و‬ ‫وم‬ ‫ا‬ ‫اض‬ ‫ث‬ ‫و‬ ‫دا‬‫داء‬...‫د‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ا‬ ‫وه‬‫ع‬ ‫ت‬ ‫ا‬ ‫أو‬ ‫ت‬ ‫و‬ ‫ا‬. -‫ا‬ ‫ا‬ ‫ا‬:‫ض‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫اء‬ ‫ء‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫و‬ ‫آ‬ ‫ا‬ ‫وي‬‫ض‬ ‫د‬ ‫ا‬ ‫ح‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫أو‬...‫و‬‫ا‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫ق‬ ‫ا‬ ‫أن‬ ‫إ‬ ‫ت‬ ‫أ‬ ‫ر‬ ‫ا‬ ‫رأ‬ ‫و‬ ‫ت‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫ة‬ ‫ا‬ ‫أه‬ ‫ل‬ ‫ا‬ ‫ن‬ ‫وه‬ ‫ا‬ ‫ا‬‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ل‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ع‬ ‫آ‬ ‫وم‬ ‫ه‬ ‫ا‬ ‫و‬. ‫رو‬ ‫ا‬ ‫ا‬ ‫ا‬Innate Immunity ‫ا‬ ‫ا‬ ‫ا‬ ‫وه‬ ‫ا‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫و‬‫ا‬ ‫ذن‬ ‫ا‬‫وم‬ ‫و‬ ‫ا‬ ‫ل‬ ‫د‬ ‫ول‬ ‫أي‬ ‫أو‬ ‫وب‬ ‫أي‬ ‫و‬ ‫و‬ ‫رب‬ ‫و‬‫ث‬ ‫و‬ ‫دا‬‫داء‬...‫ا‬ ‫وه‬ ‫د‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ع‬ ‫ا‬‫ت‬ ‫ا‬ ‫أو‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ع‬. ‫ر‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫آ‬ ‫و‬‫ا‬ ‫أ‬ ‫رة‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫آ‬ ‫أن‬ ‫و‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫و‬ ‫و‬ ‫و‬ ‫رو‬ ‫ت‬ ‫وأ‬ ‫أ‬ ‫دا‬ ‫أ‬ ‫وذ‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫و‬ ‫ده‬. ‫ا‬ ‫وا‬‫ا‬ ‫و‬ ‫ع‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ت‬ ‫وأ‬ ‫و‬ ‫أن‬ ‫ا‬ ‫إ‬ ‫ا‬ ‫ه‬ ‫و‬‫ا‬‫ا‬ ‫وا‬ ‫وا‬ ‫ا‬skin and mucus membranes‫وا‬ phagocytosis‫وا‬Complement‫ب‬ ‫وا‬Inflammation. ‫ة‬ ‫ا‬ ‫ا‬ ‫ا‬‫رو‬ ‫ا‬ ‫ا‬:‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫و‬: ١-‫را‬ ‫ا‬ ‫آ‬ ‫ا‬Genetic constitution:‫آ‬ ‫ا‬‫ا‬‫ل‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫در‬ ‫آ‬: ‫أ‬-‫اع‬ ‫ا‬Species Immunity:‫اض‬ ‫ا‬ ‫ن‬ ‫ر‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ك‬ ‫ه‬ ‫آ‬ ‫اض‬ ‫ا‬ ‫ه‬ ‫ي‬ ‫أ‬ ‫اع‬ ‫أ‬ ‫وم‬: ‫ج‬ ‫ا‬‫ا‬ ‫اض‬ ‫ا‬ ‫أ‬ ‫ع‬ ‫ب‬ ‫ا‬ ‫درا‬ ‫و‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ه‬: -‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬Infectious coryza.-‫ي‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا‬Infectious bronchitis. -‫ي‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫أ‬Infectious bursal disease.-‫ا‬ ‫ش‬ ‫ر‬ ‫ا‬Avian encephalomyelitis. -‫زس‬ ‫آ‬ ‫ا‬ ‫ورام‬ ‫ا‬Avian leucosis.-‫ر‬ ‫ض‬Marek's disease.
  21. 21. ‫ا‬‫ا‬ ‫اض‬ ‫ا‬ ‫أ‬ ‫ع‬ ‫ب‬ ‫ا‬ ‫درا‬ ‫و‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ه‬: -‫ا‬ ‫ب‬ ‫أ‬‫ا‬ ‫ء‬=‫ا‬ ‫ن‬Duck virus enteritis = Duck plague. -‫زي‬ ‫د‬ ‫ض‬Derszy's disease"‫وز‬ ‫وا‬ ‫ا‬ ‫ا‬." -‫ا‬‫و‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ب‬Duck virus hepatitis‫وز‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫آ‬ ‫ي‬ ‫وا‬. ‫و‬ ‫ا‬‫ا‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ه‬‫ا‬ ‫اض‬ ‫ا‬ ‫أ‬ ‫ع‬ ‫ب‬ ‫ا‬ ‫درا‬ ‫و‬ ‫اض‬ ‫ا‬: -‫ا‬ ‫ي‬ ‫ا‬ ‫ب‬ ‫ا‬Transmissible enteritis. -‫ا‬Histomoniasis‫د‬ ‫ا‬ ‫أس‬ ‫ا‬ ‫ض‬ ‫أو‬Black head disease. -‫ا‬Hexamitiasis. -‫رد‬ ‫ا‬ ‫أو‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫آ‬ ‫ض‬‫زس‬Bordetellosis. ‫م‬ ‫ا‬‫ا‬ ‫اض‬ ‫ا‬ ‫أ‬ ‫ع‬ ‫ب‬ ‫ا‬ ‫درا‬ ‫و‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ه‬: -‫ا‬ ‫آ‬ ‫ا‬Trichomoniasis.-‫م‬ ‫ا‬ ‫ر‬Hemoproteus infection. ‫ن‬ ‫ا‬‫اض‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ه‬‫وأه‬‫ن‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫ا‬Quail bronchitis. ‫ب‬-‫ت‬ ‫ا‬Race Immunity:‫أو‬ ‫ن‬ ‫ر‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ت‬ ‫ك‬ ‫ه‬ ‫اض‬ ‫ا‬ ‫ه‬ ‫ي‬ ‫أ‬ ‫ت‬ ‫وم‬ ‫اض‬ ‫ا‬ ‫أآ‬: -‫و‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ب‬ ‫ا‬Duck virus hepatitis‫وز‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫آ‬. -‫زي‬ ‫د‬ ‫ض‬ ‫و‬ ‫ا‬ ‫ت‬Derszy's disease‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬. -‫ي‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫أآ‬ ‫ض‬ ‫ا‬ ‫ج‬ ‫ا‬Infectious bursal disease‫ري‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫د‬. -‫آ‬‫وي‬ ‫ا‬ ‫زس‬ ‫ا‬ ‫و‬ ‫رو‬ ‫رة‬ ‫ج‬ ‫ا‬ ‫ت‬ ‫أن‬ ‫ا‬ ‫ت‬ ‫را‬ ‫ا‬. -‫ر‬ ‫ا‬ ‫ي‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬Bronze-broad breasted turkey‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ض‬Round heart‫ا‬ ‫ر‬ ‫أ‬ ‫ض‬ ‫و‬Ruptured aorta. ‫ج‬-‫د‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أو‬ ‫اد‬ ‫ا‬Individual variation:‫أآ‬ ‫ن‬ ‫ر‬ ‫ا‬ ‫اد‬ ‫أ‬ ‫ك‬ ‫ه‬ ‫ا‬ ‫أو‬ ‫ع‬ ‫ا‬ ‫ي‬ ‫أ‬ ‫اد‬ ‫أ‬ ‫اض‬ ‫ا‬‫أن‬‫أآ‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫ت‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ب‬"‫ي‬ ‫ا‬ ‫ع‬ ‫ا‬"Renal form of IB‫ن‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫ت‬. ٢-‫ا‬Age:‫ن‬‫ا‬ ‫ر‬ ‫وآ‬ ‫ر‬ ‫و‬ ‫أآ‬ ‫اض‬ ‫ا‬"‫م‬ ‫ا‬"‫ج‬ ‫ا‬ ‫ر‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ن‬ ‫آ‬ ‫ج‬ ‫ا‬ ‫ر‬ ‫أ‬ ‫ا‬ ‫ر‬ ‫وآ‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ذ‬ ‫و‬ ‫ا‬ ‫ب‬ ‫ا‬ ‫ذ‬‫ا‬ ‫ن‬ ‫و‬ ‫ا‬ ‫ر‬ ‫ه‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ازات‬ ‫أ‬ ‫ازات‬ ‫ا‬ ‫ا‬ ‫أو‬ ‫م‬ ‫أي‬ ‫اد‬ ‫ا‬ ‫ا‬ ‫دي‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫أ‬ ‫ذ‬ ‫ازات‬ ‫أ‬. -‫و‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ب‬ ‫ا‬Duck virus hepatitis‫ا‬٤٠‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫م‬. -‫زي‬ ‫د‬ ‫ض‬Derszy's disease‫وز‬ ‫وا‬ ‫ا‬ ‫ا‬٤‫ا‬ ‫ا‬ ‫ه‬ ‫و‬ ‫أ‬. -‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬. -‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫ا‬‫ا‬ ‫ج‬ ‫ا‬٥٠‫وذ‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫زوال‬. ٣-‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬Nutritional factors:‫ا‬ ‫ن‬ ‫و‬ ‫اض‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫د‬ ‫ا‬ ‫دي‬ ‫أ‬‫ء‬Leucopenia‫ا‬ ‫ا‬ ‫ط‬ ‫وا‬ ‫رة‬ ‫ا‬ ‫أو‬ Decreased phagocytic activities‫ا‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ب‬ ‫و‬ ‫أ‬ ‫ت‬ ‫أن‬ ‫وف‬ ‫ا‬ ‫و‬ ‫اض‬ ‫ا‬ ‫و‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫وا‬..‫أ‬ ‫آ‬‫ن‬ ‫ر‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫و‬ ‫ا‬. ٤-‫ا‬ ‫ا‬ ‫ا‬Hormonal factors:‫اض‬ ‫ا‬ ‫و‬ ‫ت‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ازن‬ ‫ا‬ ‫م‬ ‫د‬ ‫ب‬ ‫ا‬ ‫دات‬ ‫ام‬ ‫ا‬ ‫أن‬ ‫آ‬ ‫أ‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫و‬‫م‬ ‫ا‬
  22. 22. ‫ء‬ ‫ا‬Leucopenia‫ا‬ ‫ا‬ ‫رة‬ ‫و‬Decreased phagocytic activities‫ا‬ ‫ر‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ا‬ ‫ه‬. ٥-‫د‬ ‫ا‬ ‫ا‬Stress factors:‫ا‬ ‫ا‬ ‫ع‬ ‫وأر‬ ‫ا‬ ‫ء‬ ‫و‬ ‫ا‬ ‫م‬ ‫آ‬ ‫د‬ ‫ا‬ ‫ا‬ ‫و‬‫رة‬ ‫ض‬ ‫ا‬ ‫ا‬ ‫دي‬ ‫ا‬ ‫وا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ارة‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫د‬ ‫ض‬ ‫وا‬ ‫ن‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ط‬ ‫دة‬ ‫ز‬ ‫ا‬ ‫دي‬ ‫د‬ ‫ا‬ ‫ا‬ ‫أن‬ ‫ا‬ ‫ذ‬ ‫د‬ ‫و‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫و‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ون‬ ‫ر‬ ‫ا‬‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫د‬Leucopenia‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫ط‬ ‫وا‬ ‫رة‬ ‫ا‬Decreased phagocytic activities. ٦-‫را‬ ‫و‬ ‫ا‬:‫ا‬ ‫ت‬ ‫ا‬ ‫أ‬ ‫ر‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫دا‬ ‫ا‬ ‫را‬ ‫و‬ ‫ا‬ ‫دا‬ ‫م‬ ‫آ‬‫إن‬ ‫ء‬ ‫ا‬ ‫ا‬ ‫ا‬‫دات‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫م‬ ‫أو‬ ‫ا‬‫ا‬ ‫را‬ ‫و‬ ‫ا‬ ‫ازن‬. ٧-‫ي‬ ‫أ‬ ‫ا‬Other Factors:‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫رة‬ ‫ي‬ ‫أ‬ ‫ا‬ ‫ك‬ ‫ه‬: -‫ا‬ ‫دات‬‫دو‬ ‫وا‬:‫ا‬ ‫آ‬ ‫و‬ ‫ا‬ ‫وآ‬ ‫وا‬ ‫ل‬ ‫را‬ ‫ا‬‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫در‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫و‬ ‫اض‬ ‫ا‬ ‫ض‬ ‫و‬ ‫و‬ ‫ا‬. -‫ا‬ ‫م‬ ‫ا‬:‫ل‬ ‫اآ‬ ‫م‬ ‫و‬ ‫ء‬ ‫أ‬ ‫ر‬‫آ‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ج‬ ‫ا‬ ‫و‬ ‫ه‬. -‫ت‬ ‫وا‬ ‫ز‬ ‫وا‬ ‫ا‬:‫ا‬ ‫ز‬ ‫ا‬‫م‬ ‫و‬ ‫ا‬‫رة‬ ‫ا‬‫ع‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ا‬. -‫ت‬ ‫و‬ ‫ا‬:‫وا‬ ‫زس‬ ‫وا‬ ‫ر‬ ‫وا‬ ‫رو‬ ‫ا‬ ‫وس‬ ‫آ‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫دور‬‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫ة‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ه‬ ‫و‬. ‫رو‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬:‫ا‬ ‫ا‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬: ١-‫ا‬Skin:‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ول‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ه‬ ‫وا‬ ‫ا‬ ‫آ‬ ‫ذ‬ ‫و‬ ‫ذ‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ا‬ ‫و‬ ً ً ًً‫ا‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ذات‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬)‫ت‬ ‫و‬ ‫ت‬ ‫و‬ ‫ت‬ ‫و‬ ‫و‬(‫ذ‬ ‫و‬ ‫ا‬ ‫دا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫ا‬ ‫ا‬‫وا‬ ‫ا‬‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫رة‬ ‫ض‬ ‫ا‬ ‫ا‬ ‫ذ‬ ‫دي‬ ‫ق‬ ‫أ‬ ‫أو‬ ‫ا‬ ‫ح‬ ‫و‬ ‫ا‬ ‫وث‬ ‫اء‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ذ‬ ‫ا‬ ‫اض‬ ‫ا‬. ٢-‫ا‬ ‫رات‬ ‫ا‬Digestive juices:‫و‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫ز‬: -‫ب‬ ‫ا‬:‫ت‬ ‫و‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫ا‬ ‫اد‬ ‫ا‬ ‫ي‬. -‫ة‬ ‫ا‬ ‫از‬ ‫أ‬:‫ا‬ ‫و‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ر‬ ‫روآ‬ ‫ا‬ ‫از‬ ‫ا‬‫ا‬)pH‫أ‬ ٢(‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ت‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫إ‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ء‬ ‫اض‬ ‫ا‬ ‫ت‬ ًً‫ا‬ ‫آ‬ ‫ن‬. -‫اء‬ ‫ا‬ ‫رة‬:‫اء‬ ‫ا‬ ‫ح‬ ‫أ‬‫ا‬‫ا‬ ‫م‬ ‫وا‬‫ام‬ ‫ا‬ ‫رة‬ ‫ا‬. ٣-‫ا‬ ‫ازات‬ ‫وا‬ ‫اب‬ ‫ه‬ ‫ا‬cillary system-Muco:‫ي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫إن‬ ‫اب‬ ‫ه‬ ‫ا‬ ‫ر‬ ‫ءات‬‫ة‬ ‫ا‬ ‫ا‬ ‫وذ‬ ‫ا‬ ‫م‬ ‫ا‬ ‫ل‬ ‫و‬ ‫وا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫اج‬ ‫وا‬‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫رج‬ ‫ا‬ ‫م‬‫اء‬ ‫ا‬ ‫أه‬ ‫و‬ ‫م‬ ‫ا‬ ‫ه‬ ‫ور‬ ‫ن‬ ‫ا‬ ‫اب‬ ‫ه‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ز‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ارع‬ ‫ا‬‫ة‬ ‫آ‬ ‫ر‬ ‫ا‬ ‫و‬ ‫ه‬. ‫ا‬ ‫أو‬ ‫ا‬ ‫ازات‬ ‫ا‬ ‫أ‬‫ة‬ ‫ا‬ ‫ار‬ ‫ي‬ ‫ا‬ ‫ج‬ ‫ا‬ ‫ا‬‫ي‬ ‫آ‬ ‫أه‬ ‫ا‬ ‫ه‬ ‫د‬ ‫و‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫اب‬ ‫ه‬ ‫ا‬ ‫م‬ ‫اء‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫م‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫أو‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫رج‬ ‫ا‬ ‫م‬ ‫ا‬‫ا‬ ‫د‬ ‫و‬ ‫ا‬‫م‬ ‫و‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ت‬.
  23. 23. ٤-‫ا‬ ‫ازات‬ ‫ا‬Liquid secretions:‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ز‬ ‫و‬ ‫ا‬ ‫أو‬ ‫ي‬ ‫ا‬ ‫ث‬ ‫ن‬ ‫ا‬ ‫إ‬ ‫ت‬ ‫ا‬ ‫داد‬ ‫ا‬ ‫أ‬ ‫و‬ ‫ا‬ ‫إ‬. ٥-‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬Liquid excretions:‫ز‬ ‫ا‬ ‫إ‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫اج‬ ‫ا‬ ‫أو‬ ‫ي‬ ‫ا‬ ‫ث‬ ‫وا‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ء‬ ‫أ‬ ‫إ‬ ‫ت‬ ‫ا‬ ‫داد‬ ‫ل‬ ‫ا‬ ‫أ‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬. ٦-‫ب‬ ‫ا‬:‫ر‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ب‬ ‫ا‬Immediate Response‫وه‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫آ‬ ‫أو‬ ‫ة‬ ‫إ‬ ‫و‬ ‫أو‬ ‫ح‬ ‫أو‬ ‫ذ‬ ‫آ‬ ‫دة‬ ‫ض‬ ‫ا‬ ‫أو‬ ‫ت‬ ‫و‬ ‫وا‬ ‫آ‬ ‫ا‬ ‫ان‬ ‫و‬ ‫وا‬ ‫رم‬ ‫وا‬ ‫ا‬ ‫و‬ ‫ار‬ ‫ا‬ ‫ه‬ ‫ب‬. ‫ا‬ ‫ن‬ ‫و‬ ‫ي‬ ‫ث‬ ‫ب‬ ‫ــ‬ ‫د‬ ‫وآ‬‫و‬‫ى‬ ‫ا‬ ‫و‬ ‫ا‬ ‫د‬‫از‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫ا‬ ‫أه‬ ‫و‬ ‫ا‬ ‫و‬ ‫و‬ ‫ب‬ ‫ة‬ ‫اد‬ ‫ت‬ ‫آ‬Interleukins‫ه‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫زه‬ ‫ا‬ ‫ب‬ ‫ة‬ ‫ا‬ ‫اد‬ ‫ا‬-‫اد‬ ‫ا‬ ‫وه‬‫أ‬ ‫ورة‬ ‫ا‬ ‫ا‬ ‫ذ‬ ‫ا‬ ‫ات‬ ‫وا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ذ‬‫ا‬Capillary Permeability‫ا‬ ‫رم‬ ‫ا‬ ‫دي‬ ‫وذ‬ ‫ا‬Edema‫ا‬ ‫اد‬ ‫ا‬ ‫ذ‬ ‫آ‬ ‫ب‬ ‫ا‬ ‫ن‬ ‫وا‬ ‫م‬ ‫ا‬‫ن‬‫و‬ ‫ا‬‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ران‬ ‫ذ‬ ‫دة‬ ‫وز‬ ‫ا‬ ‫ا‬Phagocytic Cells‫ل‬ ‫ا‬ ‫أو‬ ‫ي‬ ‫ا‬ ‫ب‬Infiltration‫آ‬ ‫ا‬ ‫ه‬ ‫و‬ ‫م‬ ‫ا‬ ‫ل‬ ‫إد‬‫ا‬ ‫ا‬ ‫وه‬ ‫ا‬ ‫دا‬ ‫ت‬ ‫و‬ ‫وا‬ ‫ا‬‫ءا‬ ‫وا‬ ‫ت‬ ‫و‬ ‫أو‬ ‫ا‬ ‫ل‬ ‫وا‬ ‫م‬ ‫أي‬ ‫وا‬ ‫ا‬‫ه‬ ‫و‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ره‬ ‫وا‬‫ه‬ ‫اع‬ ‫أ‬ ‫وه‬: ١-‫و‬ ‫ا‬‫ا‬ ‫ن‬ ‫ا‬ ‫و‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫آ‬ ‫ده‬ ‫داد‬ ‫و‬‫ر‬ ‫و‬. ٢-‫ا‬Monocytes‫ا‬ ‫و‬ ‫أ‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬ ‫و‬‫م‬ ‫ا‬ ‫ده‬ ‫داد‬ ‫ا‬ ‫أ‬ ‫ل‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫د‬ ‫و‬. ٣-‫ج‬ ‫و‬ ‫ا‬Macrophages‫ا‬ ‫وه‬‫ه‬: -‫ة‬ ‫ا‬ ‫ت‬ ‫ه‬ ‫ا‬‫ا‬Tissue Macrophages‫ا‬ ‫و‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫و‬‫ا‬ ‫أ‬ ‫ب‬ ‫دا‬ ‫و‬ ‫ه‬. -‫وارة‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ه‬ ‫ا‬Circulating or Mobile Macrophages‫ا‬ ‫ت‬ ‫ا‬ ‫و‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬‫ة‬ ‫وا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫م‬ ‫ت‬ ‫و‬ ‫وا‬ ‫ا‬ ‫م‬ ‫ا‬ ‫وا‬ ‫ت‬ ‫ل‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫أدواره‬ ‫وا‬ ‫ا‬ ‫آ‬ ‫ات‬ ‫و‬ ‫أ‬ ‫ا‬ ‫ا‬ ‫ا‬‫آ‬‫ا‬ ‫وا‬ ‫دة‬ ‫ا‬ ‫م‬. -‫ع‬ ‫و‬‫ا‬ ‫ار‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬‫وه‬‫ا‬‫ا‬ ‫ا‬Natural Killers‫ا‬ ‫و‬ ‫وه‬‫وه‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬‫وا‬ ‫آ‬ ‫ا‬ ‫ف‬ ‫و‬ ‫أ‬ ‫دا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ى‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ت‬ ‫و‬ ‫وا‬ ‫ا‬ ‫م‬ ‫ا‬ ‫م‬ ‫أ‬ ‫أ‬. ٧-‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ارة‬ ‫در‬:‫أر‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ارة‬ ‫در‬"٤٢ ‫در‬"‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫رأ‬ ‫و‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫در‬ ‫ا‬ ‫وه‬ Spore-forming bacteria‫أن‬ ‫آ‬ ‫د‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫وآ‬ ‫ا‬ ‫أ‬ ‫ا‬ ‫و‬‫ا‬ ‫ا‬ Pyogenic bacteria‫ر‬ ‫ا‬ ‫دا‬ ‫ا‬ ‫أ‬‫ر‬ ‫ا‬ ‫اع‬ ‫أ‬. ٨-‫ا‬ ‫م‬ ‫ا‬ ‫ا‬Alternative pathway of complement activation:‫اد‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫و‬ ‫و‬ ‫م‬ ‫ا‬ ‫آ‬"‫و‬ ‫آ‬." ‫ا‬ ‫ا‬‫ـ‬ ‫ا‬ ‫وه‬ ‫ا‬ ‫دة‬ ‫ا‬ ‫م‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫د‬ ‫و‬IgM & IgG ‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫وأ‬ ‫ا‬ ‫رو‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ه‬.
  24. 24. ‫و‬ ‫أي‬ ‫وث‬ ‫د‬ ‫وب‬ ‫ا‬ ‫م‬ ‫و‬ ‫ا‬ ‫ا‬ ‫أ‬‫ا‬ ‫ا‬ ‫دون‬ ‫و‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫م‬ ‫أ‬. ٩-‫ت‬ ‫و‬ ‫ا‬Interferons:‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ه‬Glycoproteins‫آ‬ ‫ا‬ ‫وأ‬ ‫أ‬-‫ا‬ ‫رض‬-‫ا‬ ‫ر‬ ‫و‬ ‫وس‬ ‫ا‬ ‫رض‬ ‫أ‬‫ا‬ ‫و‬ ‫و‬ ‫و‬ ‫و‬ ‫وا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫ج‬ ‫آ‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ز‬ ‫و‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ا‬ ‫ورة‬ ‫ا‬ ‫ا‬)‫وس‬ ‫ا‬ ‫ا‬ ‫أي‬(‫ل‬ ‫ا‬ ‫دا‬ ‫وس‬ ‫ا‬ ‫خ‬ ‫ا‬)‫و‬ ‫ا‬ ‫وي‬ ‫ا‬ ‫ا‬(‫وإ‬ ‫وس‬ ‫ون‬ ‫وا‬ ‫ا‬ ‫د‬ ‫آ‬ ‫ز‬"‫وس‬ ‫و‬ ‫أ‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ Species specific and not virus specific"‫و‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫أن‬ ‫آ‬‫ت‬‫ا‬ ‫ا‬ ‫دور‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫آ‬)Inhibition of B-cell activation(‫ا‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ط‬ ‫ا‬ ‫و‬ ‫ا‬)enhancement of the cytotoxic activity of natural Killer cells(‫رة‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬intercellular parasites‫ـ‬ ‫ا‬chlamydiae‫ـ‬ ‫وا‬rickettsiae‫ـ‬ ‫ا‬ ‫زوا‬ ‫و‬ ‫وا‬ Toxoplasma‫ـ‬ ‫ا‬ ‫ا‬ ‫وا‬streptococci‫ـ‬ ‫وا‬staphylococci‫ا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫و‬endotoxins ‫ا‬ ‫وأه‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫و‬ ‫ا‬ ‫أو‬ ‫ارة‬ ‫ت‬ ‫و‬ ‫ا‬ ‫و‬: ‫أ‬-‫ا‬ ‫ون‬ ‫ا‬:‫و‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫م‬ ‫و‬: ١-‫ون‬ ‫ا‬)IFN-α(‫ا‬ ‫ا‬ ‫وا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫دات‬ ‫و‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫ز‬ ‫و‬ )NK(‫ء‬ ‫ا‬ ‫ا‬ ‫ون‬ ‫ا‬ ‫و‬Leucocyte interferon. ٢-‫ون‬ ‫ا‬)IFN-β(‫ز‬ ‫و‬‫و‬ ‫ا‬fibroblast‫ا‬ ‫وا‬epithelial cells ‫ا‬ ‫ـ‬ ‫و‬ ‫ت‬ ‫و‬ ‫د‬ ‫ـ‬ ‫ه‬ ‫ا‬ ‫ودور‬ ‫ج‬ ‫و‬ ‫آ‬ ‫وا‬Fibroepithilial interferon. ‫ب‬-‫ا‬ ‫ون‬ ‫ا‬:‫و‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫م‬‫ون‬ ‫ا‬IFNγ‫ا‬ ‫ز‬ ‫و‬- ‫ا‬‫ا‬ ‫ون‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ودور‬ ‫ج‬ ‫و‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ة‬Immune interferon‫رو‬ ‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫وه‬. ١٠-‫آ‬ ‫ا‬ ‫ا‬Phagocytic cells:‫ا‬ ‫و‬‫ا‬ ‫و‬‫ا‬ ‫وا‬ ‫ا‬ ‫ورة‬ ‫ا‬ ‫ة‬ ‫و‬ ‫آ‬ ‫ة‬ ‫ا‬Macrophages‫ا‬‫ف‬ ‫ا‬ ‫م‬ ‫ا‬ ‫و‬ ‫ع‬ ‫م‬ ‫ه‬ ‫وآ‬ ‫ا‬ ‫ة‬ ‫و‬ Phagocytosis‫أآ‬ ‫ا‬١٨٨٢‫ف‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫م‬"١٨٤٥-١٩١٦"‫م‬. ‫و‬‫ا‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫آ‬‫و‬ ‫وس‬ ‫أو‬ ‫ى‬ ‫وأ‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ور‬ ‫ا‬ ‫ع‬ ‫أي‬ ‫ون‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫آ‬ ‫وم‬ ‫وإ‬ ‫أو‬ ‫ا‬ ‫وق‬ ‫ا‬ ‫أو‬ ‫وح‬ ‫ا‬ ‫ل‬ ‫ذ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫اض‬ ‫ا‬ ‫ت‬ ‫ن‬ ‫رو‬ ‫ا‬ ‫ط‬ ‫ر‬ ‫ا‬‫ا‬)‫وا‬ ‫وا‬ ‫ا‬ ‫ا‬(‫ل‬ ‫ا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫اع‬ ‫أ‬ ‫ن‬E.Coli‫ل‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ض‬ ‫ا‬ ‫و‬. ‫ا‬ ‫ا‬munityAcquired Im ‫ا‬ ‫آ‬ ‫ة‬ ‫ا‬ ‫أه‬ ‫ا‬ ‫و‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫رو‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫وا‬ ‫ق‬ ‫ا‬ ‫إن‬ ‫رج‬ ‫إ‬ ‫ت‬ ‫أ‬ ‫ر‬ ‫ا‬ ‫رأ‬ ‫و‬ ‫ت‬ ‫ر‬ ‫ا‬ ‫ذآ‬ ‫آ‬ ‫رت‬ ‫و‬ ‫ا‬ ‫ن‬ ‫وه‬ ‫ا‬ ‫ا‬‫و‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫و‬ ‫ل‬ ‫ل‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ع‬ ‫آ‬ ‫وم‬ ‫ه‬ ‫ا‬. ‫و‬‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ك‬)‫ا‬ ‫ا‬ ‫ء‬ ‫ا‬ ‫م‬ ‫ا‬ ‫آ‬ ‫وا‬‫ا‬ ‫و‬ ‫ا‬ ‫وا‬ ‫ا‬ ‫وا‬ ‫ج‬ ‫و‬(‫ء‬ ‫وأ‬)‫وا‬ ‫وا‬ ‫ا‬ ‫ة‬ ‫ا‬‫ل‬ ‫ردر‬ ‫ه‬ ‫ة‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ز‬ ‫وا‬(‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬‫و‬‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ًً ‫ا‬ ‫وا‬ ‫ء‬ ‫وا‬"‫ز‬ ‫ا‬‫ا‬"Immune system).(
  25. 25. ‫رو‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫و‬: ١-‫ا‬ ‫ا‬ ‫ا‬ ‫اد‬ ‫ا‬ ‫أو‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ل‬ ‫د‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫دور‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫وم‬ ‫ا‬ ‫ا‬ ‫اذا‬ ‫ه‬ ‫رد‬ ‫ي‬ ‫م‬‫ا‬ ‫وأ‬ ‫آ‬ ‫ا‬ ‫اض‬ ‫أ‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫إذا‬ ‫ه‬ ‫و‬ ‫ي‬ ‫ا‬ ‫ا‬ ‫ب‬ ‫وا‬ ‫ر‬ ‫ا‬. ٢-‫ا‬ ‫ب‬ ‫وا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫وأ‬ ‫آ‬ ‫ا‬ ‫اض‬ ‫أ‬ ‫ت‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ي‬ ‫ا‬‫ي‬ ‫ت‬ ‫و‬. ٣-‫ا‬"‫ة‬ ‫ذاآ‬"‫ة‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫أي‬ ‫د‬ ‫إذا‬ ‫أ‬ ‫أي‬ ‫ا‬ ‫ز‬ ‫ا‬ ‫ن‬ ‫ا‬"‫ف‬"‫و‬ ‫و‬ ‫ءة‬ ‫و‬ ‫و‬. ‫ا‬ ‫ا‬Immune response: ‫ا‬‫ا‬ ‫م‬ ‫ا‬ ‫ج‬ ‫أ‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫دة‬ ‫ا‬Antibody-mediated immune responses‫ا‬ ‫ا‬ ‫وا‬Cell-mediated immune Response‫ا‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ة‬ ‫وا‬Activated Immune cells. ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫ا‬: ‫أو‬-‫ا‬ ‫ا‬ ‫ا‬:‫ا‬ ‫أو‬ ‫ا‬Antigen‫ا‬ ‫ز‬ ‫آ‬ ‫دة‬ ‫آ‬ ‫ه‬ ‫أو‬ ‫ت‬ ‫و‬ ‫ا‬ ‫أو‬ ‫ى‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫م‬ ‫أ‬ ‫و‬ ‫ه‬ ‫م‬ ‫ا‬‫ت‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫آ‬ ‫اد‬ ‫ا‬ ‫وه‬ ‫ه‬ ‫و‬ ‫و‬ ‫را‬ ‫ه‬ ‫آ‬ ‫أو‬ ‫و‬ ‫ء‬ ‫إ‬ ‫أو‬ ‫و‬ ‫أو‬ ‫أو‬ ‫دة‬ ‫أ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫رة‬ ‫ا‬ ‫ره‬‫ا‬ ‫ت‬‫ا‬ ‫ا‬ ‫ز‬‫و‬‫و‬ ‫ت‬ ‫و‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ا‬ ‫وا‬ ‫ت‬ ‫أ‬ ‫ه‬ ‫اد‬ ‫ا‬ ‫ه‬ ‫و‬ ‫ب‬ ‫ا‬ ‫أو‬ ‫ن‬ ‫ا‬ ‫ا‬: ١-‫ا‬ ‫ا‬Foreignness:‫ا‬ ‫اد‬ ‫ا‬ ‫ا‬ ‫ز‬ ‫ا‬Non-self‫أ‬‫ا‬ Self‫ذا‬ ‫اف‬ ‫أ‬ ‫ث‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ا‬ ‫ه‬ ‫أ‬ ‫ث‬ Autoimmune diseases. ٢-‫ا‬ ‫زن‬ ‫ا‬Molecular weight:‫وا‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫زن‬ ‫ا‬ ‫زاد‬ ‫آ‬ ‫زن‬ ‫د‬ ‫ا‬‫ه‬ ‫ا‬ ‫ز‬ ‫ي‬ ‫ا‬ ‫ا‬١٠٠٠٠‫ن‬ ‫دا‬. ٣-‫ا‬ ‫آ‬ ‫ا‬Chemical composition:‫رة‬ ‫أآ‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫آ‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫آ‬ ‫و‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ا‬‫و‬ ‫أ‬ ‫اد‬ ‫ا‬ ‫أآ‬ ‫ق‬ ‫ا‬ ‫أ‬ ‫رة‬ ‫ن‬ ‫ه‬ ‫ا‬ ‫أ‬ ‫ه‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ت‬ ‫آ‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫ة‬ ‫ت‬ ‫آ‬ ‫ا‬. ٤-‫ا‬ ‫ا‬Physical nature:‫ا‬ ‫رة‬ ‫ا‬ ‫أآ‬ ‫ذا‬ ‫ا‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫م‬ ‫ا‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أن‬ ‫آ‬ ‫ا‬ ‫ا‬Denaturated‫ا‬ ‫أ‬ ‫أآ‬. ٥-‫ا‬Degradability:‫آ‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫أن‬ ‫و‬Phagocytosis‫أآ‬ ‫ن‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أن‬ ‫ذ‬ ‫وا‬ ‫ه‬ ‫ا‬ ‫رة‬ ‫ا‬‫ا‬ ‫دات‬Epitopes ‫ت‬ ‫و‬. -‫ا‬ ‫ا‬ ‫ا‬:‫و‬: -‫را‬ ‫ا‬ ‫ا‬ ‫ا‬:‫ت‬ ‫ا‬ ‫ع‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫اع‬ ‫أ‬ ‫ك‬ ‫ه‬Responders‫ا‬ ‫أ‬ ‫أن‬ ‫ت‬ ‫ا‬ ‫ه‬ ‫ي‬ ‫أ‬Non-responders‫ا‬ ‫ا‬ ‫ذ‬ ‫و‬‫را‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫ف‬ ‫ا‬ ‫و‬ ‫و‬ ‫ا‬ ‫و‬ ‫ت‬ ‫د‬ ‫و‬ ‫ا‬ ‫دي‬ ‫ي‬ ‫وا‬ ‫ا‬ ‫و‬ ‫اع‬ ‫ا‬ ‫ه‬. -‫ا‬:‫ر‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ا‬ ‫ا‬ ‫أ‬ ‫ن‬ ‫ة‬ ‫ا‬ ‫أو‬ ‫ة‬ ‫ا‬ ‫ر‬ ‫ا‬‫ا‬ ‫ن‬ ‫و‬ ‫ن‬ ‫ة‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أن‬ ‫ذ‬‫ز‬ ‫ا‬ ‫ن‬ ‫ة‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫و‬ ‫ر‬ ‫وا‬ ‫ا‬ ‫ا‬ ‫زه‬ ‫زال‬ ‫و‬ ‫ر‬ ‫و‬ ‫ا‬ ‫زه‬ ‫ن‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫أ‬ ‫م‬ ‫ا‬ ‫أ‬ ‫ا‬ . -‫ول‬ ‫ا‬ ‫ا‬ ‫ا‬:‫و‬:

×